Plant pest control

Description of equivalent WO 9844137 A2

PLANT PEST CONTROL

The present invention relates to a novel class of proteins for the control of plant pests.

Plant pests are a major factor in the loss of the world's commercially important agricultural crops resulting both in economic hardship to farmers and nutritional deprivation for local populations in many parts of the world. Broad spectrum chemical pesticides have been used extensively to control or eradicate pests of agricultural importance. There is, however, substantial interest in developing effective alternative pesticides.

Control of various pests through the use of biological molecules has been possible in only a limited number of cases. The best known examples of biological molecules with pesticidal uses are the δ-endotoxins from Bacillus thuringiensis (Bt), which is a gram-positive spore forming microorganism. Varieties of Bt are known that produce more than 25 different but related δ-endotoxins. Bt strains produce δ-endotoxins during sporulation the use of which is limited because they are active against only a very few of the many insect pests.

The limited specificity of the Bt endotoxins is dependent, at least in part, on both the activation of the toxin in the insect gut (Haider, . Z. et al., 1986, Eur. J. Biochem. 156:531-540) and its ability to bind to specific receptors present on the insect" s midgut epithelial cells (Hofmann, C. P. etal., 1988, PNAS 85:7844-7848). Therefore, the ability to control a specific insect pest using δ-endotoxins at present depends on the ability to find an appropriate δ- endotoxin with the desired range of activity. In many cases, no such δ-endotoxin is known, and it is not certain that one even exists.

Plants also routinely become infected by fungi and bacteria, and many microbial species have evolved to utilize the different niches provided by the growing plant. In addition to infection by fungi and bacteria, many plant diseases are caused by nematodes which are soil-borne and infect roots, typically causing serious damage when the same crop species is cultivated for successive years on the same area of ground.

The severity of the destructive process of disease depends on the aggressiveness of the phytopathogen and the response of the host, and one aim of most plant breeding programs is to increase the resistance of host plants to disease. Novel gene sources and combinations developed for resistance to disease have typically only had a limited period of successful use in many crop-pathogen systems due to the rapid evolution of phytopathogens to overcome resistance genes.

It is apparent, therefore, that scientists must constantly be in search of new methods with which to protect crops against plant pests. It has been found in the present invention a novel class of proteins which can be used to control plant pests.

Programmed cell death is a process whereby developmental or environmental stimuli activate a genetic program that culminate in the death of the cell (Jacobson, M.D. et al., 1997,Cell 88: 347-354). This genetic potential exists in most, if not all, multicellular organisms. In the case of invertebrates, programmed cell death appears to play a dual role by being an integral part of both the insect development process and a response mechanism to infections particularly of viral nature (Clem, R.J. et al., 1991.Science 254: 1388-1390). Programmed cell death appears to be executed in several different manners leading to either apoptosis, atrophy or differentiation. Apoptosis is one of the best characterized types of programmed cell death encompassing cytological changes including membrane-bound apoptotic bodies and cytoplasmic blebbing as well as molecular changes such as endonucleolysis typified by the generation of oligosomal length fragments (Vaux, D.L and Strasser, A., 1996, PNAS 93:2239-2244). Although the overall apoptotic phenomenology is rather conserved among the different organisms, it is interesting to point out that, for many insect cells, cytoplasmic vacuolization and swelling rather than condensation seem to be the cytological features associated with apoptotic processes

(Bowen, I.D., er a/., 1996, Micros. Res. Techniq.34:202-217). The novel class of proteins disclosed within the present invention are shown to induce programmed cell death and exert a pesticidal effect.

The present invention is drawn to VIP3A(c) proteins including homoiogues thereof. Also provided by the invention are domains of proteins of the VIP3 class, including the toxic domain and the stabilizing domain. A preferred embodiment of the invention is the toxic domain of the VIP3A(a) protein and homoiogues thereof. Another preferred embodiment are antibodies to proteins of the VIP3 class, but preferably to the VIP3A(c) protein.

The invention also provides hybrid toxins comprising a toxic domain of a protein of the VIP3 class. In a preferred embodiment, the hybrid toxin is a chimeric proteins having a toxic core domain operably linked to a heterologous stabilizing domain. In another preferred embodiment, the hybrid toxin comprises an antibody, or immunologically-active fragment thereof, which immunologically recognizes the VIP3 receptor operably linked to a toxic domain from other proteins, wherein the toxin domain is obtained from a number of cytotoxic proteins including but not limited to Bacillus toxins, including endotoxins and vegetative insecticidal proteins.

Also encompassed by the invention are plants comprising a DNA sequence which encodes a protein of the VIP3 class, but preferably a VIP3A(c) protein. Preferred embodiments include plants selected from the group consisting of maize, sorghum, wheat, sunflower, tomato, cole crops, cotton, rice, soybean, sugarbeet, sugarcane, tobacco, barley, and oilseed rape. In a particularly preferred embodiment, the plant is a maize plant.

The invention also provides microorganisms comprising a heterologous DNA sequence which encodes a protein of the VIP3 class, but preferably a VIP3A(c) protein. In a preferred embodiment, the microorganism is selected from the group consisting of bacteria, baculovirus, algae and fungi. In another preferred embodiment, the microorganism is selected from the group consisting of Bacillus, Pseudomonas, Clavibacter, and Rhizobium. Further encompassed by the invention are entomocidal compositions comprising microorganisms comprising a heterologous DNA sequence which encodes a protein of the VIP3 class, but preferably a VIP3A(c) protein.

The invention further relates to plants and microorganisms further comprising a second DNA sequence which encodes a second insecticidal protein. Particularly preferred second DNA sequences are those which encode a δ-endotoxin, those which encode another protein of the VIP3 class, or those which encode a protein of the VIP1 or VIP2 classes. In a more preferred embodiment, the δ-endotoxin is active against an insect selected from the group consisting of Lepidoptera and Coleoptera. In a more particularly preferred embodiment the δ-endotoxin is active against Ostrinia, or Diabrotica. In another particularly preferred is a second DNA sequence which encodes a δ-endotoxin protein selected from the group consisting of Cry1 , Cry3, Cry5 and Cry9. In a more particularly preferred embodiment, the δ-endotoxin is selected from the group consisting of CrylAa, CrylAb, CrylAc, Cryl B, Cryl C, Cryl D, Cryl Ea, Cryl Fa, Cry3A, Cry9A, Cry9C and Cry9B. Most particularly preferred are δ-endotoxins selected from the group consisting of CrylAb, CrylBa and Cry9C proteins.

The invention further provides a method of controlling insects by contacting the insects with an insecticidal amount of a protein of the VIP3 class, but preferably a VIP3A(c) protein, or an insecticidal amount of a chemical ligand to a receptor of the VIP3 class of proteins. In one preferred embodiment, the insects are contacted with a transgenic plant comprising a DNA sequence which expresses a protein of the VIP3 class, but preferably a VIP3A(c) protein In another preferred embodiment, the insects are contacted with a an entomocidal composition comprising a protein of the VIP3 class, but preferably a VIP3A(c) protein, or comprising a DNA sequence which expresses a protein of the VIP3 class, but preferably a VIP3A(c) protein. In another preferred embodiment, the transgenic plant comprises a DNA sequence which expresses the VIP3A(a) protein. In another preferred embodiment the insect is selected from the group consisting of Coleoptera, Diptera, Hymenoptera, Lepidoptera, Mallophaga, Homoptera, Hemiptera, Orthroptera, Thysanoptera, Dermaptera, Isoptera, Anoplura, Siphonaptera, Trichoptera, and Acari. In a particularly preferred embodiment, the insect is a Coleoptera or Lepidoptera. In another particularly preferred embodiment, the insect is selected from the group consisting of black cutworm (Agrotis ipsilon ), fall armyworm (Spodoptera frugiperda), beet armyworm (S. exigua), yellow striped armyworm (S. omithogalli), southwestern corn borer (Diatraea grandiosella), sugarcane borer (D. saccharalis), corn earworm (Helicoveφa zea), mediterranean corn borer (Sesamia nonagroides ), cabbage looper (Trichoplusia ni), velvetbean caterpillar (Anticarsia gemmatalis), diamondback moth (Plutella xylostella) and tobacco budworm (Heliothis virescens).

Also provided by the invention is a method of controlling insects wherein the transgenic plant or microorganism further comprises a second DNA sequence which encodes a second insecticidal protein such as those mentioned hereinbefore.

The invention further provides recombinant DNA sequences which encode a VIP3A(c) protein including homoiogues thereof. In another preferred embodiment, the DNA sequence is a synthetic sequence which has been altered for optimum expression in a plant, particularly where the DNA sequence has been optimized for expression in a maize plant. Also preferred are DNA sequences which comprise both a synthetic portion and a native portion. In a particularly preferred embodiment, the DNA sequence encoding the VIP3A(c) protein has been optimized for expression in a maize plant. Another preferred embodiment are DNA sequences which are homologous to a DNA sequence which encodes a VIP3A(c) protein. Particularly preferred are DNA sequences which hybridize _. under moderately stringent conditions to the vp3A(c) coding sequence. Yet another embodiment of the invention is a recombinant DNA sequence which expresses a protein of the VIP3 class, preferably a VIP3A(c) protein, under the control of a heterologous promoter, or wherein the coding regions is incorporated into the genome of an organism where it is not naturally expressed or is expressed at higher levels than that occuring naturally.

The invention is further drawn to a method of identifying and isolating homoiogues of a VIP3A(c) protein, or of a DNA sequence which encodes said protein.

Also provided by the invention are expression cassettes comprising a promoter operably linked to a DNA sequence encoding a protein of the VIP3 class, but preferably a VIP3A(c) protein. In one preferred embodiment the promoter is selected from the group consisting of constitutive, tissue-preferred and tissue-specific promoters for expression in plants. In a particularly preferred embodiment, the promoter is selected from the group consisting of the ubiquitin, PEP carboxylase, LPT and MTL promoters. In another preferred embodiment, the promoter is functional in a microorganism.

The invention further provides a receptor to a protein of the VIP3 class and DNA sequences which. In one embodiment of the invention, the receptor comprises a death domain and a repeated EGF-motif. A more preferred embodiment of the invention comprises a receptor to the VIP3A(a). A more particularly preferred embodiment is the receptor protein sequence set forth in SEQ ID NO:9, and homoiogues thereto. Also encompassed by the invention are DNA sequences which encode these receptor proteins, e.g., the DNA sequence set forth in SEQ ID NO:8 and homoiogues thereto. The cDNA for the VIP3 receptor is contained in plasmid pCIB7113, which was deposited under the Budapest Treaty with the NRRL [Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Illinois 61604, USA] on March 29, 1997 and has accession number B-21676. Antibodies to a receptor of the VIP3 class of proteins are also encompassed by the invention.

Also provided by the invention is a method of identifying a compound as a VIP3 receptor chemical ligand having pesticidal activity comprising exposing a cell, preferably an insect cell, to a test compound, and assaying said cell for apoptotic activity. In another embodiment of the invention, the method comprises measuring specific binding between VIP3 receptor and a test compound. A preferred embodiment are VIP3 receptor ligands identified by the method.

Definitions

"Plant pest" means any organism known to associate with plants and which, as a result of that association, causes a detrimental effect on the plant's health and vigor. Plant pests include but are not limited to fungi, bacteria, insects, and nematodes. The term plant as used herein encompasses whole plants and parts of plants such as roots, stems, leaves and seed, as well as cells and tissues within the plants or plant parts.

The NIP3 class of proteins" comprises VIP3A(a), VIP3A(b) VIP3A(c) and their homoiogues. "Homologue" is used throughout to mean that the indicated protein or polypeptide bears a defined relationship to other members of the VIP3 class of proteins. This defined relationship includes but is not limited to, 1 ) proteins which are at least 70%, more preferably 80% and most preferably 90% identical at the sequence level to another member of the VIP3 class of proteins while also retaining pesticidal activity, 2) proteins which are cross-reactive to antibodies which immunologically recognize another member of the VIP3 class of proteins, 3) proteins which are cross-reactive with a receptor to another member of the VIP3 class of proteins and retain the ability to induce programmed cell death, and 4) proteins which are at least 70%, more preferably 80% and most preferably 90% identical at the sequence level to the toxic core region of another member of the VIP3 class of proteins while also retaining pesticidal activity.

A "hybrid toxin" is used to indicate a genetic fusion, having domains operably linked so that, when translated, a functional chimeric protein is formed having, in the aggregate, the properties of the individual domains. "Domain" is used to indicate a region or portion of a protein or confers a recognizable function or structure which contributes to the overall functionality of the protein. It is recognized that a DNA sequence which encodes a protein domain is also encompassed by this definition.

"Heterologous" is used to indicate that a protein, polypeptide or nucleotide sequence has a different natural origin with respect to its current host. For example, if a p3A(a) gene from a Bacillus thuringiensis is genetically transformed into a plant cell, then the gene is described as being heterologous with respect to its current host, which is the plant cell. Furthermore, if a wp3A(a) gene from Bacillus thuringiensis is genetically transformed into a Pseudomonas bacterium, then the gene is also described as being heterologous with respect to the Pseudomonas. "Heterologous" is also used to indicate that one or more of the domains present in a chimeric protein, polypeptide or nucleotide sequence differ in their natural origin with respect to other domains present. For example, if the toxic domain from VIP3A(a) protein is fused to the binding domain from the VIP1 A(a) protein to make a functional insecticidal protein, then the chimeric fusion would have domains that are heterologous to each other. In addition, a heterologous chimeric protein or polypeptide comprising the fusion of a toxic domain from VIP3A(a) protein to the binding domain from the VIP1A(a) protein, when expressed in a plant, would also be considered heterologous with respect to the plant host.

The term "chimeric" is used to indicate that the protein, polypeptide, or nucleotide sequence is comprised of domains at least one of which has an origin that is heterologous with respect to the other domains present. These chimeric proteins or polypeptides are encoded by chimeric nucleotide sequences which have been fused or ligated together resulting in a coding sequence which does not occur naturally. Such chimeric constructions may also be designated as "recombinant."

"Expression cassette" as used herein means a DNA sequence capable of directing expression of a gene in plant cells, comprising a promoter operably linked to an amino acid coding region which is operably linked to a termination region. The gene may be chimeric, meaning that at least one component of the gene is heterologous with respect to at least one other component of the gene. The gene may also be naturally occurring, but which has been obtained in a recombinant form useful for genetic transformation of a plant or microorganism.

Figures

Figure 1 : Amino acid sequence of the receptor for VIP3A(a) translated from the cDNA. Several features of the protein are shown: dotted line - signal peptide (amino acid 13 to 35); italic - domain spanning the putative death domain (amino acid 81 -205); double underline - sequences with strong homology to sequences found in consensus death domains; bold - CKC motif repeated six times spanning the EGF-motifs; underline - sequences repeated within the EGF-motifs.

Arthropod Pests

For purposes of the present invention, pests include insects and arachnids selected from the orders Coleoptera, Diptera, Hymenoptera, Lepidoptera, Mallophaga, Homoptera, Hemiptera, Orthroptera, Thysanoptera, Dermaptera, Isoptera, Anoplura, Siphonaptera, Trichoptera, and Acari, particularly Coleoptera and Lepidoptera.

A list of pests associated with major crop plants are provided, for example, in Tables 1-10 on pages 13 to 20 of WO 96/10083, which is incorporated herein by reference. Further pests are provided in the following Tables 1 - 8. Such pests are included within the scope of the present invention. Table 1 : Lepidoptera (Butterflies and Moths)

Maize Crucifers (broccoli, cabbage, cauliflower, coilards)

Sesamia nonagroides, Mediterranean Artogeia rapae, imported cabbageworm corn borer

Ostrinia fumacalis, Asian com borer Pieris brassicae, cabbage butterfly Trichoplusia ni, cabbage looper

Cotton Plutella xylostella, diamondback moth Helicoverpa armigera , cotton bollworm Spodoptera exigua, beet armyworm Agrotis ipsilon, black cutworm

Rice Agrotis segetum, common cutworm Chilo suppressalis, asiatic rice borer Mamestra configura, bertha army worm Scirpophaga sp.

Grapes

Tomato Endopiza viteana, grape berry moth

Helicoverpa zea, tomato fruitworm Spodpptera exigua, beet armyworm Deciduous Fruits and Nuts Spodoptera frugiperda, fall armyworm Cydia pomonella, codling moth Spodoptera omithogalli, yellowstriped Platynota idaeusalis, tufted apple bud moth armyworm Spodoptera praefica, western yellowstriped armyworm Spodoptera eridania, southern Peppers armyworm Agrotis ipsilon, black cutworm Ostrinia nubilalis, European com borer Peridroma saucia, variegated cutworm Spodoptera exigua, beet armyworm Papaipema nebήs, stalk borer Spodoptera eridania, southern armyworm Trichoplusia ni, cabbage looper Keiferia lycopersicella, tomato pinworm Potato Manduca sexta, tobacco homworm Ostrinia nubilalis, European corn borer Manduca quinquemaculata, tomato Phthorimaea operculella, potato tuberworm homworm

Canola Plutella xylostella, diamondback moth

Sugarcane Diatraea saccharalis, sugarcane borer

Table 2: Coleoptera (Beetles)

Rice Potato Oulema oryzae, rice beetle Leptinotarsa decemlineata, Colorado potato, beetle

Epitrix cucumeris, potato flea beetle

Tomato Hemicrepidus memnonius, wireworms

Leptinotarsa decemlineata, Colorado potato Melanpotus spp., wireworms beetle

Epitrix hirtipennis, tobacco flea beetle Canola

Crucifers (broccoli, cabbage, cauliflower, Ceutorhychus assimilis, cabbage seedpod weevil coilards) Phyllotreta cruciferae, crucifer flea beetle Phyllotreta cruciferae, crucifer flea beetle Phyllotreta pusilla, westem black flea beetle

Peppers Anthonomus eugenii, pepper weevil

Table 3: Homoptera (Whiteflies. Aphids etc..)

Rice Melon Nilaparvata lugens Bemisia argentifolii, silverleaf whitefly Sogatella furcifera Bemisia tabaci, sweetpotato whitefly Laodelphaax striatellus

Carrot

Tomato Cavariella aegopodii, carrot aphid Myzus persicae, green peach aphid Macrosiphum euphorbiae, potato aphid Canola Trileurodes vaporariorum, greenhouse whitefly Brevicoryne brassicae, cabbage aphid Bemisia tabaci, sweetpotato whitefly Bemisia argentifolii, silverleaf whitefly Vegetables Aphis fabae, bean aphid

Crucifers (broccoli, cabbage, cauliflower, coilards) Brevicoryne brassicae, cabbage aphid Sugar Beet Myzus persicae, green peach aphid Pemphigus popullivenae, sugar beet root aphid

Peppers Deciduous Fruits and Nuts Myzus persicae, green peach aphid Dysaphis plantaginea, rosy apple aphid

Potato Sugarcane Empoasca fabae, potato leafhopper Saccharosydne saccharivora, West Indian canefly

Myzus persicae, green peach aphid Sipha flava, yellow sugarcane aphid Macrosiphum euphorbiae, potato aphid Paratrioza cockerelli, potato psyllid

Table 4: Hemiptera (Bugs)

Tomato lygus bug

Acrostemum hilare, green stink bug Euschistus servus, brown stick bug

Table 5: Orthoptera (Grasshoppers. Crickets, and Cockroaches)

Wheat

Melanoplus sanguinipes, migratory grasshopper Table 6: Diptera (Flies and Mosquitoes)

Tomato Carrot Liriomyza trifolii, leafminer Psilia rosae, carrot rust fly Liriomyza sativae, vegetable leafminer Scrobipalpula absoluta, tomato leafminer Sugarbeet

Tetanops myopaeformis, sugarbeet root maggot

Crucifers (broccoli, cabbage, cauliflower, coilards) Delia brassicae, cabbage maggot Vegetables Delia radicum, cabbage root fly Liviomyza sativae, vegetable leaf miner

Table 7: Thvsanoptera (Thrips)

Tomato Peppers Frankliniella occidentakis, western flower thrips Thrips palmi, melon thrips Frankliniella fusca, tobacco thrips Thrips tabaci, onion thrips Potato Thrips palmi, melon thrips

Crucifers (broccoli, cabbage, cauliflower, coilards) Thrips tabaci, onion thrips

Table 8: Acari (Mites and Ticks)

Tomato Tetranychus urticae, two-spotted spider mite Aculops lycopersici, tomato russet mite Steneotarsonemus pallidus, cyclamen mite

Citrus Panonychus citri, citrus red mite Brevipalpus lewisi, citrus flat mite Phyllocoptrutra oleivora, citrus rust mite

Deciduous Fruits and Nuts Panonychus ulmi, European red mite Tetranchus sp, spider mite

For purposes of the present invention, pests also include fungal phytopathogens of plants. A list of fungal pests associated with major crop plants is provided in Table 9. Such pests are included within the scope of the present invention. Table 9: Funαal Diseases of Plants

Ear Molds Gibberella ear mold Gibberella zeae

G. saubinetti

Aspergillus ear rot Aspergillus flavus

A. parasiticus

Diplodia ear rot Diplodia maydis

D. macrospora

Fusarium ear rot Fusarium moniliforme

F. monilif. var. subglutinans

Stalk Rots Pythium stalk rot Pythium aphanidermata Anthracnose stalk rot Colletotrichum graminicola

C. tucumanensis Glomerella graminicola

Diplodia stalk rot Diplodia maydis

D. zeae-maydis Stenocarpella maydis Macrodiplodia zeae Sphaeria maydis

S. zeae

D. macrospora

Fusarium stalk rot Fusarium moniliforme Gibberella stalk rot G. zeae G. saubinetti

Stewart's wilt & leaf blight Erwinia stewartii

Leaf Diseases Northern corn leaf blight Exserohilum turcicum Southern corn leaf blight Bipolaris maydis Gray leaf spot Cercospora zeae-maydis C. sorghi var. maydis

Anthracnose leaf blight Colletotrichum graminicola Common rust Puccinia sorghi P. maydis

Southern rust Puccinia polysora Dicaeoma polysorum

Head smut Sphacelotheca reiliana Common smut Ustilago maydis Carbonum leaf spot Helminthosporium carbonum Eye spot Kabatiella zeae

Downy Mildews Sorghum downy mildew Peronosclerospora sorghi Brown stripe downy mildew Sclerophthora rayssiae Sugarcane downy mildew Peronosclerospora sacchari Philiipine downy mildew Peronoscler. philippinensis Java downy mildew Peronosclerospora maydis Spontaneum downy mildew Peronosclerospora spontanea Rajasthan downy mildew Peronosclerospora heteropogoni Graminicola downy mildew Sclerospora graminicola

Rusts Puccinia graminis f.sp. tritici Puccinia recondita f.sp. tritici Puccinia striiformis

Smuts Tilletia tritici Tilletia controversa Tilletia indica Ustilago tritici Urocystis tritici

Root rots, Foot rots and Blights Gaeumannomyces graminis Pythium spp. Fusarium culmorum Fusarium graminaerum Fusarium avenaceum Drechslere tritici-repentis Rhizoctonia spp. Colletotrichum graminicola Helminthosporium spp. Microdochium nivale Pseudocercosporella herpotrichoides

Mildews Erysiphe graminis f.sp. tritici Sclerophthora macrospora

Miscellaneous Fungal Diseases Septoria tritici Septoria nodorum

The proteins of the VIP3 class are secreted to the media by Bacillus spp. in vegetative stages of growth. VIP3A(a) is a member of a newly discovered class of proteins displaying insecticidal activity against a broad spectrum of lepidopteran insects including black cutworm (Agrotis ipsilon ), fall armyworm (Spodoptera frugiperda), beet armyworm (S. exigua), yellow striped armyworm (S. ornithogalli), southwestern corn borer (Diatraea grandiosella), sugarcane borer (D. saccharalis), corn earworm (Helicoveφa zea), Mediterranean corn borer (Sesamia nonagroides ), cabbage looper (Trichoplusia ni), velvetbean cateφillar (Anticarsia gemmatalis), diamondback moth (Plutella xylostella) and tobacco budworm (Heliothis virescens). Some of these lepidopteran insects have been shown to be very resistant to other insecticidal proteins such as δ-endotoxin. For example, the reported LC₅₀ for Cry1 A(c), which is one of the most effective δ-endotoxin against black cutworm, is greater than 6000 ng/cm² (Macintosh et al., J. Invertebr. Pathol. 56:258-266 (1990)). In contrast, it takes 260-fold less of VIP3A(a) protein to kill 50% of the black cutworm larvae. Thus, the VIP3A(a) protein displays a unique spectrum of insecticidal activities.

The present invention provides a new member of the VIP3 class of proteins, the VIP3A(c) protein isolated from strain AB51 (pCIB71 12 deposited on March 28, 1997 as Accession No. NRRL B-21675; all deposits were made in accordance with the Budapest Treaty by submission to the Agricultural Research Service, Patent Culture Collection (NRRL), Northern Regional Research Center, 1815 North University Street, Peoria, Illinois 61604, USA) as disclosed in SEQ ID NO:5-6..

The VIP3A(c) protein encoding DNA sequence was identified and isolated s through the use of PCR technology. In particular, primer sequences can be made which recognize either conserved or variable regions of the coding sequence, and are then used to screen DNA samples obtained from either known or unknown strains.

It is recognized that there are multiple approaches to identifying and isolating homoiogues within the VIP3 class of proteins and the DNA sequences which encode them, which approaches are well known to those skilled in the art.

The DNA and protein sequences for the VIP3A(a) and VIP3A(c) proteins are aligned in Table 12.

Table 12: Alignment of VIP3A(a) (Upper Line) against VIP3A(c) (Lower Line)

1 MNKN TKLSTRALPSFIDYFNGIYGFATGIKDIMNMIFKTDTGGDLTLDE 50 SEQ ID NO: 2

1 MNKN AKLSTRALPSFIDYFNGIYGFATGIKDIMNMIFKTDTGGDLALDE 50 SEQ ID NO: 6

51 ILKNQQLLNDISGKLDGVNGSLNDLIAQGNLNTELSKEILKIANEQNQVL 100

51 ILENQQLLNDISGKLDGλ/NGSLNDLIAQGNLNTELSKEILKIANEQNQVL 100

101 NDVNNKLDAINTMLRVYLPKITSMLSDVMKQNYALSLQIEYLSKQLQEIS 150

101 NDVNNKLDAINTMLRVYLPKITSMLSDVMKQNYALSLQIEYLSKQLQEIS 150

151 DKLDIINVNVLINSTLTEITPAYQRIKYVNEKFEELTFATETSSKVKKDG 200

14 151 DKLDI INVNVLINSTLTEITPAYQRIKYVJ^KFEELTFATETSSKVKKBG 200 201 SPADILDE TELTEI_u?- SVTKNDVrX3FEFΥT^TFHDVMVGNNLFGRSALK 250

M i l l

201 SPADIRDELSELTELAKSVTQNDVDGFEFYLNTFHDVMVGNNLFGRSALK 250 251 TASELIT ENVKTSGSEVGNVYNFLIV TALQAQAF TLTTCRKLLGLAD 300

1111111 ! ! ! 1 E 11 i ! 111 ! 1111111111 ! i I ! 11 ! I i ! - 1111 J 11 i I

251 TASELITKSTVTTSGSEVGNVYNFLIVLTALQAQAFLTLTPCRKLLGLAD 300 301 IDYTSIMNEHLNKEKEEFRVNILPTLSN FSNPNYAKVKGSDEDAK IVE 350

301 IDYTSII^EHLNKEKEEFRVNILPTLSNTFSNPNYAKVKGSDEDAKMIVE 350 351 AKPGHALIGFEISNDSITVLKVYEAKLKQNYQVDKDSLSEVIYGDMDKLL 400

; i 11111 i 1111 S 1111111 E 11 i 111 i 1111 i E E ! i 11111111 i 11 ! i

351 AKPGHALIGFEISNDSITVLKVYEAKLKQNYQVDKDSLSEVIYGDMDKLL 400 401 CPDQSEQIYYTNNIVFPNEYVITKIDFTKKMKTLRYEVTANFYDSSTGEI 450

401 CPDQSGQIYYTNNIVFPNEYVITKIDFTKKMKTLRYEVTANFYDSSTGEI 450 451 DLNKKKVESSEAEYRTLSANDDGVYMPLGVISETFLTPINGFGLQADENS 500

! ! I ' 1111111 ! 111 ! 1111111 S 1 ! ! ! 111 i 1111111111111 ! I ! 11

451 DLNKK VESSEAEYRTLSANDDGVYMPLGVISETFLTPINGFGLQADENS 500 501 RLITLTCKSYLRELLLATDLSNKETKLIVPPSGFISNIVENGSIEEDNLE 550 i 11111111 ! 111 E 11 ! i 11 ! 11 ! E 11111 ! 11 i 11 i 111 E 111 i 111 E

501 RLITLTCKSYLRELLLATDLSNKETKLIVPPSGFISNIVENGSIEEDNLE 550 551 P KANNKNAYVDHTGGVNGTKALYVHKDGGISQFIGDKLKPKTEYVIQYT 600

551 PllKlAlNlNlKlNlAlYlVlDlHlTlGlGlVlNlGlTlKlAlLlYlVlHlKlDlGlGlIlSlQlFlIlGlDlKlLlKlPlKlTlElYlVlIlQlYlTl 600 601 VKGKPSIHLKDENTGYIHYEDTNNNLEDYQTINKRFTTGTDLKGVYLILK 650

601 VlKlGlKlPlSlIlHlLlKlDlElNlTlGlYlIlHlYlElDlTlNlNlNlLlElDlYlQlTlIlNlKlRlFlTlTlGlTlDlLlKlGlVlYlLlIlLlKl 650 651 SQNGDEA GDNFIILEISPSEKLLSPELINTNNWTSTGSTNISGNTLTLY 700

M I ! I ! M 111 M ! 11 E 111 ! 1111 ! II 111111 M 111 M M 11111 ! I

651 SQNGDEAWGDNFIILEISPSEKLLSPELINTNNWTSTGSTNISGNTLTLY 700 701 QGGRGILKQNLQLDSFSTYRVYFSVSGDANVRIRNSREVLFEKRYM 746 ^■■

701 QGGRGILKQNLQLDSFSTYRVYFSVSGDANVRIRNSREVLFEKKDI 746

Polypeptide Domains ofthe VIP3 Class of Proteins

It has been shown that the VIP3A(a) protein undergoes proteolytic processing when mixed with the gut fluids of insect larvae. When gut fluids isolated from black cutworm are mixed with purified VIP3A(a), four major proteolytic products derived from VIP3A(a) can be identified having a molecular weight of approximately 66, 45, 33 and 22 kDa. The 22 kDa band comprises the N-terminal portion of the VIP3A(a) protein from amino acid 1 to amino acid 198 of SEQ ID NO:2. The 66 kDa band comprises the rest of the VIP3A(a) protein from amino acid 200 to amino acid 789 of SEQ ID NO:2. Both the 45 and 33 kDa bands are derived by proteolysis from the 66 kDa band and constitute amino acid 412 to amino acid 789, and from amino acid 200 to amino acid 455, respectively, of SEQ ID NO:2. The 33 kDa band is the main component of the VIP3A(a) protein that remains after an incubation period of more than two hours. This 33 kDa "toxic core" domain (amino acids 200 to 455 of SEQ ID NO:2) of the VIP3A(a) protein retains full insecticidal properties against a broad spectrum of lepidopteran insects. Similar results are obtained when VIP3A(a) is incubated with gut fluids isolated from fall armyworm, another insect sensitive to VIP3A(a).

In addition to the toxic core domain, the VIP3A(a) protein also possesses a stabilizing domain at the C-terminus. The role of the stabilizing domain was explored using mutants of the VIP3A(a) protein and the VIP3A(c) protein, neither of which display insecticidal properties when ingested by insects known to be sensitive to VIP3A(a). When similar studies addressing the stability in black cutworm gut fluid was conducted with VIP3A(a)- mutants, in particular with a mutant of the VIP3A(a) protein that contains three point mutations located at the carboxy-terminal domain (amino acid 742 (E→D); amino acid 770 (S→P); and amino acid 784 (Y→H)), it was found that the protein was completely hydrolyzed. Similar results were obtained for the VIP3A(c) (SEQ ID NO:6) protein isolated from AB51 , which shares an overall identity of 96% with the VIP3A(a) protein but lacks the carboxy-terminal domain of VIP3A(a). Both the mutant and VIP3A(c) protein, however, are active against the insect cell line Sf-9. These results indicate that the function of the carboxy-terminal domain of proteins of the VIP3 class is to provide stability to the protein in the gut environment of susceptible insects.

Hybrid Toxins Comprising a VIP3 Region and a Heterologous Region

Toxins, enzymes, transcription factors, antibodies, cell binding moieties or other protein domains can be operably linked to the novel proteins of the present invention by producing in frame genetic fusions which, when translated by ribosomes, would produce a fusion protein with the combined attributes of the VIP and the other component used in the fusion. Furthermore, if the protein domain fused to the VIP has an affinity for another protein, nucleic acid, carbohydrate, lipid, or other chemical or factor, then a three- component complex can be formed. This complex will have the attributes of all of its components. A similar rationale can be used for producing four or more component complexes. These complexes are useful as insecticidal toxins, pharmaceuticals, laboratory reagents, and diagnostic reagents, etc. Examples where such complexes are currently used are fusion toxins for potential cancer therapies, reagents in ELISA assays and immunoblot analysis.

The hybrid toxins of the invention include chimeric proteins having a toxic core domain which is heterologous to the stabilizing domain. Hybrid toxins are also created by combining an antibody, or immunologically-active fragment thereof, which immunologically recognizes the VIP3 receptor with a toxic domain from other proteins. The toxin domain is obtained from a number of cytotoxic proteins. These include but are not limited to Bacillus toxins, including endotoxins and vegetative insecticidal proteins. See for example US application serial no. 08/037,057, filed March 25, 1993 and U.S. application serial no. 07/951,715 filed September 25, 1992, herein incorporated by reference. Other toxins include catalytic ribosome inactivators such as gelonin, Pseudomonas exotoxin A or phytolaccin, (die structure of Pseudomonas exotoxin has been well characterized in Chaudhary etal, J. Biol. Chem. 265:16303-16310 (1990)); cell metabolism disrupters, such as ribonucleases, (see, for example, Mariani et al. Nature 347:737-741 (1990)); Bamase toxin (or PE- Bar), a chimeric toxin derived from Pseudomonas exotoxin A and a ribonuclease, (see, Prior et al. Cell 64:1017-1023 (1991)); hydrophilic peptides that create pores in membranes (see, Frohlich and Wells, Int. J. Peptide Protein Res. 37:2-6 (1991)).

Mode of Action of VIP3A(a)

The VIP3A(a) protein has been shown to be active against a broad spectrum of plant pests. For example, histopathological observations indicate that VIP3A(a) ingestion by susceptible insects such as black cutworm (Agrotis ipsilon) and fall armyworm (Spodoptera frugiperda) causes gut paralysis at concentrations as low as 4 ng/cm² of diet, with complete lysis of the gut epithelial cells resulting in larval death at concentrations above 40 ng/cm². Less susceptible insects like European corn borer (Ostrinia nubilalis) do not develop any pathology upon ingesting VIP3A(a). While the proteolytic processing of the VIP3A(a) protein by midgut fluids obtained from susceptible and non-susceptible insects is comparable, in vivo immuno-localization studies show that VIP3A(a) binding is restricted to gut cells of susceptible insects. Therefore, the insect host range for VIP3A(a) seems to be determined by its binding ability to gut cells. Histopathological observations indicate that midgut epithelial cells of susceptible insects are the primary target for the VIP3A(a) insecticidal protein and their subsequent lysis is the primary mechanism of lethality. Programmed cell death is an active process of self-destruction that seems to be important for development and maintenance of multicellular organisms (Clem, R.J. et al. Science 254: 1388-1390 (1991)). Cells undergoing apoptosis, which is a form of programmed cell death, generate membrane-bound apoptotic bodies and activate endogenous nucleases that cleaves the chromatin into discrete fragments. SF-9 insect cells derived from S. frugiperda exposed to the VIP3A(a) protein undergo a series of cytological and molecular changes including membrane protrusions, profuse vacuolization and endonucleolysis which are indicative of an apoptotic-type of programmed cell death. Histological studies have shown that the VIP3A(a) protein targets midgut epithelial cells of susceptible insects initiating a series of cytological changes comprising profuse vacuolization and swelling prior to cell lysis and larval death. These midgut cells also experienced an endonucleolysis process when exposed to the VIP3A(a) protein as revealed by in situ detection of DNA fragmentation. These results indicate that VIP3A(a) exerts its insecticidal properties on susceptible insect cells by triggering an apoptotic-type of programmed cell death.

The Receptor for VIP3A(a) has been Isolated

The immunohistochemistry results provided above indicate that VIP3A(a) has the ability to bind to the apical membranes of midgut epithelial cells and that this binding triggers the process that will eventually end with cell lysis. This indicates that there exists one or more proteins located in the apical membrane that recognize and bind to VIP3A(a) acting as a receptor. This receptor signals the interaction with VIP3A(a) and triggers the process of apoptosis. Thus, the receptor will mediate the response of the insect cell to VIP3A(a).

To isolate this receptor, a cDNA library was screened which was made from mRNA isolated from midgut tissue of black cutworm. The objective of the screen was to identify and isolate cDNA sequences which encode proteins that will interact with VIP3A(a) in the two hybrid system (see Fields, S. and Song, O.-K. Nature 340:245-246 (1989)). This approach resulted in the identification and isolation of one cDNA whose encoded protein strongly interacted with the VIP3A(a) protein. This 1.75 Kb-long cDNA (SEQ ID NO:8) encodes a protein of approximately 48 kDa (396 amino acids; see SEQ ID NO:9). The cloned cDNA is similar in size to the mRNA encoding the cDNA as analyzed by Northern. A portion of the DNA sequence which encodes the first 5 to 20 amino acids may be missing. The following features can be identified in the cDNA encoded protein (see Figure 1 ): 1) it contains a signal peptide; 2) it contains a domain with homology to the so-called death domain (Feinstein, E. et al. Trends in Biochem. 20:342-344 (1995)); and 3) it contains EGF- like motifs or repeats (Fantl, W.J. et al. Annu. Rev. Biochem. 62:453-481 (1993)). A search of protein databases using the receptor of VIP3A(a) showed homology with a family of extracellular glycoproteins known as Tenascins (Pearson, CA. et al. EMBO J. 7:2677-2681 (1988)) or Hexabrachion (Nies, D.E. et al. J. Biol. Chem. 266:2818-2823 (1991)). This family of proteins contains EGF-like repeats, interacts with multiple ligands, and performs a role in cell adhesion and/or signaling. The combination of a death domain and repeated EGF-motifs as observed in the VIP3 receptor is unique among programmed cell death receptors.

In addition, a portion of the VIP3A(a) receptor shares homology with the so-called "death domain." The death domain is a 60 to 70 amino acid long motif which is involved in protein to protein interaction and is shared by proteins with diverse cellular functions (Feinstein, E. et al. Trends in Biochem. 20:342-344 (1995)). Some of the protein members containing death domain motifs include receptors known to be associated with apoptotic processes. Some examples include the Fas receptor (Brakebush, C. et al. EMBO J. 11 :943-950 (1992)) and the tumor necrosis factor (TNF) (Tartaglia, L.A. et al. Cell 74:845- 853 (1993)).

Homoiogues to the VIP3A(a) receptor can be identified and isolated by various means, for example, by nucleic acid hybridization. Southern blot analysis can be performed on DNA samples taken from insect cells or fungal cells that has been enzyme restricted, run in agarose and blotted onto nitrocellulose and/or nylon filters. The Southern blot can be probed with the full-or partial length of the nucleic acid encoding the receptor of the VIP3A(a) protein under low stringency hybridization and washing conditions. The genes can be readily cloned and sequenced from a cDNA or genomic library. A size-selected genomic library can also be obtained to facilitate cloning of the gene(s) of interests. The technical protocols to perform the experiments outlined above are readily available (see for instance Molecular Cloning, A Laboratory Manual, Second Edition, Vols. 1-3, Sambrook et al. (eds.) Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY (1989) and reference therein).

Antibodies to VIP3A(a) and its Receptor Polyclonal and monoclonal antibodies to a VIP3 protein or its receptor, including fragments thereof which immunologically recognize a portion of either protein, are provided. The antibody and monoclonal antibodies of the present invention can be prepared by utilizing a VIP3 protein or its receptor as the antigen.

The antibodies of the invention include polyclonal and monoclonal antibodies as well as fragments thereof which retain their ability to bind a VIP3 protein or its receptor. An antibody, monoclonal antibody, or fragment thereof is said to be capable of binding a molecule if it is capable of specifically reacting with the molecule to thereby bind the molecule to the antibody, monoclonal antibody, or fragment thereof. The term "antibody" (Ab) or "monoclonal antibody" (Mab) is meant to include intact molecules as well as fragments or binding regions or domains thereof (such as, for example, Fab and F(ab)₂ fragments) which are capable of binding hapten. Such fragments are typically produced by proteolytic cleavage, such as papain or pepsin. Alternatively, hapten-binding fragments can be produced through the application of recombinant DNA technology or through synthetic chemistry.

Methods for the preparation of the antibodies of the present invention are generally known in the art. For example, see Antibodies, A Laboratory Manual, Ed Harlow and David Lane (eds.) Cold Spring Harbor Laboratory, NY (1988), as well as the references cited therein. Standard reference works setting forth the general principles of immunology include: Klein, J. Immunology: The Science of Cell-Noncell Discrimination, John Wiley & Sons, NY (1982); Dennett, R., et al. Monoclonal Antibodies, Mybridoma: A New Dimension in Biological Analyses, Plenum Press, NY (1980); and Campbell, A. "Monoclonal Antibody Technology," In Laboratory Techniques in Biochemistry and Molecular Biology, Vol. 13, Burdon et al. (eds.), Elsevier, Amsterdam (1984). See also, US Patent Nos: 4,609,893; 4,713,325; 4,714,681 ; 4,716,111 ; 4,716,117; and 4,720,459.

It is recognized that following the methods described herein, antibodies specific for a particular VIP3 protein or its receptor can be generated. The subset of MAb lines which possess the desired binding specificity can be used as a source of messenger RNA for cloning of the cDNA for the particular monoclonal antibody.

The cloned DNA can then be sequenced by methods known in the art. See, for example, Sambrook et al., Molecular Cloning: A Laboratory Manual, 2nd. Edition, Cold Spring Harbor Laboratory Press, NY (1989) vol. 1-3, and the references cited therein. From the nucleic acid sequence, the protein sequence of the binding region from the selected MAb can be deduced. One use of the antibodies and monoclonal antibodies of the invention includes but is not limited to the production of hybrid toxin molecules. T at is, when linked, the monoclonal antibody or antibody fragment retains its binding properties and the toxin moiety retains its cytotoxic properties.

Various methods are known for obtaining antibody genes. One method is to clone a random library of antibody genes in a phage and screen the library for ability to bind to a VIP3 protein or its receptor. Another available approach is to generate monoclonal antibodies which bind to a VIP3 protein or its receptor and then clone the antibody genes from such lines. For the present example, the second method is used. Antibody genes can be cloned from hybridoma cells using primers to conserved DNA sequences within the constant regions and the framework regions of the variable regions and amplified for cloning using the polymerase chain reaction (PCR). See generally, Mullis et al., Meth. Enzymol., 155:335-350 (1987); Erlich, (ed.), PCR Technology, Stockton Press (New York 1989). A database of mouse heavy chain and light chain sequences compiled by Kabat et al., US Dept Health and Human Services, US Government Printing Offices (1991 ) has been successfully used to generate both isotype specific and degenerate primers for cloning antibody genes. (Jones et al. Bio/technology 9:88-89 (1991 )). Additionally, techniques are well known for cloning of smaller fragments of antibodies (Fab) which possess the binding properties of the original antibody. Complete antibodies are large molecules (150 kDa), but much smaller Fab and Fv antigen-binding fragments (12 kDa-50 kDa) have been shown to retain full binding affinity. Single chain Fv fragments (scFv) in which Vh and VI domains are linked by a hydrophilic and flexible peptide have been used successfully to target enzymes and toxins to specific cells (Bird, Science 423:423-426 (1988); Huston, PNAS 85:5879-5883 (1988)). Single Vh domains (Dabs) and single complementary determining regions as small as 20 amino acids in length, called minimal recognition units (m.r.u.), have also been used for antigen binding (Ward, Nature 341 :544-546 (1989); Taub, J. Biol. Chem 264:259-265 (1989); Williams, PNAS 86:5537-5541 (1989)). Thus, it is possible to reduce the binding domain specific for a VIP3 or its receptor to a very small size.

Polymerase chain reaction technology and specific oligonucleotide primers are used to clone immunoglobulin genes or regions from immunoglobin genes. PCR primers specific for both the heavy and light chains of IgM and the three IgG isotypes were selected from the Kabat database described above. Primers for the region encoding the NH₂-terminal end of the mature variable region were designed to initiate at the first framework region and were made with some degeneracy to allow these to be used as "universal primers". The 3' primers used for the specific PCR amplification of the variable regions were designed from conserved sequences of the first constant domain (CH1) of both the light and heavy chains. A different 3' primer is used for immunoglobulin isotypes lgG1 , lgG3, and IgM. Isotypes lgG2A and lgG2B can be amplified with the same primers used for lgG1. Antibody variable regions are cloned into a light and heavy chain expression vector containing an endoplasmic reticulum signal peptide and the constant regions of lgG1 light and heavy chains, respectively.

Primer sequences used for the PCR cloning of the mouse immunoglobulin light and heavy variable regions are available in the published literature (Coloma et al. Bio/Techniques 11 : 152-156 (1991 ); Jones et al. Bio/Technology 9:88-89 (1991)). Oligonucleotides were made on an Applied Biosystems DNA synthesizer 380B (Applied Biosystems, Foster City, CA) using standard conditions as described below. The PCR primers incoφorate restriction sites and, after amplification and digestion, can be cloned into a plant expression vector under the control of a plant-expressible promoter. Restriction sites were chosen that were known to be absent in sequenced antibody genes.

Another use of the polyclonal and/or monoclonal antibodies of the invention includes the stimulation of apoptosis by targeting the receptor to Vip3A with antibodies. The interaction of antibodies raised against cell surface-located proteins that are involved in controlling the cell growth result in the induction of apoptosis by means of preventing the said receptor from binding to its natural ligand(s). For instance, the anti-APO-1 antibody completely blocks proliferation of leukemia cells bearing the APO-1 protein and triggers apoptosis in these cells (Trauth, B.C. et al. Science 245:301-305 (1989)). Also, the activity resulting from the interaction between a given receptor and a ligand is mimicked by substituting the ligand for antibodies raised against the receptor. For instance, the addition of certain anti-Fas antibodies to cells bearing the Fas receptor in their cell surfaces will mediate apoptosis in a similar fashion as when the ligand of the Fas receptor is added (Itoh, N. et al. Cell 66:233-243 (1991 )).

The receptor to Vip3A(a) isolated from black cutworm shares homology with a family of extracelular glycoproteins known as Tenascins, and in particular with Tenascin-X (Bristow, J. et al. J. Cell Biol. 122:265-278 (1993)). Tenascin-Xs are known to be involved in cell-to-cell adhesion and signaling. Lack of functionality of Tenascin-X either by mutation or by removal of the gene leads to lethality. Therefore, antibodies raised against different domains of the receptor to Vip3A(a) either effectively block the receptor from binding to its ligand(s) or mimic the interaction of the Vip3A(a) protein triggering apoptosis. This approach is extended to different receptors with similar biological functions. In this sense, antibodies raised against insect cell receptors involved in crucial cell growth and interaction processes lead to induction of apoptosis and are used as an strategy to control insects.

Screening for Novel Insecticidal Activities whose Mode of Action is Apoptosis

The materials described in this invention are used to screen for chemical ligands that have pesticidal properties triggering apoptotic responses. Chemical ligands include small organic molecules, peptides, and proteins. In one embodiment of the invention, insect cell lines are used as model organisms for insects to screen for compounds that are insecticidal as a consequence of their ability to induce apoptosis. These cell lines are handled in a high- throughput screening format where the cells are grown in multi-well plates and are exposed to a variety of compounds. Yeast is also used as a model organism. Using procedures described herein or known in the art, determining whether a compound is pesticidal as a consequence of inducing apoptosis is accomplished.

One means by which to identify compounds that trigger apoptotic responses through interaction with a known receptor is to resort to identified receptors involved in the signal transduction pathway triggered in apoptotic insect cell lines. These receptors are transformed into heterologous cell lines creating isogenic lines with one of them containing a gene for expression of a specific receptor and another one which does not either possess, or express, such a gene. These cell lines are handled in a high-throughput screening format whereby the transformed cell lines expressing the receptor have a differential response against compounds that trigger apoptosis through their specific interaction with said receptor.

Also encompassed by the present invention is the characterization of biochemical and/or molecular markers that specifically identify an insect cell line undergoing apoptosis. For example, it is possible to isolate specific cDNAs induced during an apoptotic process in specific insect cell lines. Although the death core pathway seems to be phylogenetically conserved (Nagata, S. Cell 88:355-365 (1997)), the signal transduction pathway from the receptor to the death core pathway is subject to variation across organisms. Messenger RNAs differentially expressed in insect cells undergoing apoptosis are identified by a number of techniques readily available such as differential display (Bauer, D. et al. Nucleic Acid Res. 21 :4272-4280 (1993)) or subtractive libraries ( Sommer, H. et al. EMBO J. 9:605- 613 (1990)). The differentially expressed cDNA-encoded proteins are used as markers for apoptosis in specific insect cell lines. Transgenic Plants Comprising a DNA Sequence Encoding a Protein ofthe VIP3 Class

A host plant expressing at least one of the sequences of the invention has enhanced resistance to attack by plant pests and is thus better equipped to withstand crop losses associated with such attack. By plant is meant any plant species which can be genetically transformed by methods known in the art. Methods known in the art for plant transformation are discussed below. Host plants include, but are not limited to, those species previously listed as target crops.

PLANT EXPRESSION CASSETTES Methodologies for the construction of plant expression cassettes as well as the introduction of foreign DNA into plants are described in the art. Such expression cassettes may include promoters, terminators, enhancers, leader sequences, introns and other regulatory sequences operably linked to the pesticidal protein coding sequence. It is further recognized that promoters or terminators of the VIP3 genes can be used in expression cassettes.

Toxin genes derived from microorganisms may also differ from plant genes. Plant genes differ from genes found in microorganisms in that their transcribed RNA does not possess defined ribosome binding site sequence adjacent to the initiating methionine. Consequently, microbial genes can be enhanced by the inclusion of a eukaryotic consensus translation initiator at the ATG (Kozak, Cell 44:283-292 (1986)). Clontech (1993/1994 catalog, page 210) has suggested the sequence GTCGACCATGGTC (SEQ ID NO:—) as a consensus translation initiator for the expression of the E. coli uidA gene in plants. Further, Joshi (Nucleic Acids Res. 15: 6643-6653 (1987)) has compared many plant sequences adjacent to the ATG and suggests the consensus TAAACAATGGCT (SEQ ID NO:—). In situations where difficulties are encountered in the expression of microbial ORFs in plants, inclusion of one of these sequences at the initiating ATG may improve translation. In such cases the last three nucleotides of the consensus may not be appropriate for inclusion in the modified sequence due to their modification of the second AA residue. Preferred sequences adjacent to the initiating methionine may differ between different plant species. By surveying the sequence of maize genes present in the GenBank/EMBL database it can be discerned which nucleotides adjacent to the ATG should be modified to enhance translation of the toxin gene introduced into maize. ln addition, it has been shown that removal of illegitimate splice sites can enhance expression and stability of introduced genes. Genes cloned from non-plant sources and not optimized for expression in plants may contain motifs which can be recognized in plants as 5' or 3' splice sites. Consequently, the transcription process can be prematurely terminated, generating truncated or deleted mRNA. The toxin genes can be engineered to remove these illegitimate splice sites using multiple techniques. For example, several available methods can be utilized to identify potential splice sites in a DNA sequence. First, potential splice sites may be identified by computer analysis of the DNA sequence. Consensus sequences which identify splice sites are known in the art. See, for example, Goodall, GJ. and Filipowicz, W., EMBO J. 10, 2635-2644 (1991 ) and Brown, J.W.S., Nucleic Acids Research 14, 9549-9559 (1986). Alternately, one can identify splice sites actually processed by a plant by comparing PCR analysis of cDNA derived from the gene with actual gene products. Shorter than expected products are indicative of splicing. Such smaller products are then cloned and sequenced and the exact location of the splice determined. It is also recognized that a combination of computer searching and PCR analysis can be utilized.

The novel toxin genes of the present invention, either as their native sequence or as optimized synthetic sequences as described above, can be operably fused to a variety of promoters for expression in plants including constitutive, inducible, temporally regulated, developmentally regulated, chemically regulated, tissue-preferred and tissue-specific promoters to prepare recombinant DNA molecules, i.e., chimeric genes. Preferred constitutive promoters include the CaMV 35S and 19S promoters (Fraley et al., U.S. Patent No. 5,352,605, issued October 4, 1994). An additionally preferred promoter is derived from any one of several of the actin genes, which are known to be expressed in most cell types. The promoter expression cassettes described by McElroy et al. (Mol. Gen. Genet. 231 : 150- 160 (1991 )) can be easily modified for the expression of the novel toxin gene and are particularly suitable for use in monocotyledonous hosts.

Yet another preferred constitutive promoter is derived from ubiquitin, which is another gene product known to accumulate in many cell types. The ubiquitin promoter has been cloned from several species for use in transgenic plants (e.g. sunflower - Binet et al. Plant Science 79: 87-94 (1991), maize - Christensen et al. Plant Molec. Biol. 12: 619-632 (1989)). The maize ubiquitin promoter has been developed in transgenic monocot systems and its sequence and vectors constructed for monocot transformation are disclosed in the patent publication EP 0 342 926. The ubiquitin promoter is suitable for the expression of the novel toxin gene in transgenic plants, especially monocotyledons.

Other promoters useful for the expression of the novel toxin gene in plants, particularly maize, are, for example, tissue-specific or tissue-preferential promoters such as those disclosed in WO 93/07278; chemically inducible promoters disclosed in EP-A 0 332 104, herein incoφorated by reference in its entirety.

In addition to promoters, a variety of transcriptional terminators are also available for use in chimeric gene construction using the novel toxin gene of the present invention. Transcriptional terminators are responsible for the termination of transcription beyond the transgene and its correct polyadenylation. Appropriate transcriptional terminators and those which are known to function in plants include the CaMV 35S terminator, the tml terminator, the nopaline synthase terminator, the pea rbcS E9 terminator and others known in the art. These can be used in both monocotyledons and dicotyledons.

A number of non-translated leader sequences derived from viruses such as those reported in, for example, WO 96/10083 are also known to enhance expression, and these are particularly effective in dicotyledonous cells. Specifically, leader sequences from Tobacco Mosaic Virus (TMV, the "Ω-sequence"), Maize Chlorotic Mottle Virus (MCMV), and Alfalfa Mosaic Virus (AMV) have been shown to be effective in enhancing expression (e.g. Gallie et al. Nucl. Acids Res. 15: 8693-8711 (1987); Skuzeski et al. Plant Molec. Biol. 15; 65-79 (1990))

Various intron sequences have been shown to enhance expression when added to the 5' regulatory region, particularly in monocotyledonous cells. For example, the introns of the maize Adh 1 gene have been found to significantly enhance the expression of the wildtype gene under its cognate promoter when introduced into maize cells (Callis et al., Genes Develop. 1 :1183-1200 (1987)).

OPTIMIZING V/p3 GENES FOR PLANT EXPRESSION

The pesticidal genes of the invention can be optimized for enhanced expression in plants. See, for example, EPA 0359472; EPA 0385962; WO 91/16432; and, Perlak et al., Proc. Natl. Acad. Sci. 88:3324-3328 (1991 ). in this manner, the coding sequences can be synthesized which are optimized for plant expression.

In one embodiment of the invention the v/p3A(a) is made according to the procedure disclosed in U.S. Ser. No. 07/951 ,715, herein incoφorated by reference. In this procedure, maize preferred codons, i.e., the single codon which most frequently encodes that amino acid in maize, are used. The maize preferred codon for a particular amino acid may be derived, for example, from known gene sequences from maize. Maize codon usage for 28 genes from maize plants is found in Murray et al., Nucleic Acids Research 17: 477-498 (1989), the disclosure of which is incoφorated herein by reference. Examples of synthetic sequences made with maize optimized codons are set forth in SEQ ID NO:7 (VIP3A(a)), in SEQ ID NO:19 (VIP3A(b)), and in SEQ ID NO:20 (VIP3A(c)).

In this manner, the nucleotide sequences can be optimized for expression in any plant. It is recognized that all or any part of the gene sequence may be optimized or synthetic. That is, synthetic or partially optimized sequences may also be used.

PLANT TRANSFORMATION

The recombinant DNA molecules can be introduced into the plant cell in a number of art-recognized ways. Those skilled in the art will appreciate that the choice of method might depend on the type of plant, i.e. monocot or dicot, targeted for transformation. Suitable methods of transforming plant cells are described, for example, in WO 96/10083 and WO 97/46105, respectively, including microinjection, electroporation, Agrobacterium-medlated transformation, direct gene transfer, and ballistic particle acceleration using devices available from Agracetus, Inc., Madison, Wisconsin and Dupont, Inc., Wilmington, Delaware.

An preferred embodiment is the protoplast transformation method for maize as disclosed in European Patent Application EP 0 292 435, as well as in U. S. Patent Number 5,350,689, hereby incorporated by reference in its entirety. One particularly preferred set of embodiments for the introduction of the expression cassettes of the present invention into wheat by microprojectile bombardment can be found in U. S. Patent No. 5,610,042 herein incorporated by reference in its entirety.

Transformation of plants can be undertaken with a single DNA molecule or multiple DNA molecules (i.e. co-transformation), and both these techniques are suitable for use with the expression cassettes of the present invention. Numerous transformation vectors are available for plant transformation, and the expression cassettes of this invention can be used in conjunction with any such vectors. The selection of vector will depend upon the preferred transformation technique and the target species for transformation.

Many vectors are available for transformation using Agrobacterium tumefaciens. These typically carry at least one T-DNA border sequence and include vectors such as pBIN19 (Bevan, Nucl. Acids Res. (1984)). In one preferred embodiment, the novel toxin gene of the present invention may be inserted into either of the binary vectors pCIB200 and pCIB2001 for use with Agrobactenum, the construction of which is disclosed, for example, in WO 95/33818 (example 35) (see also EP 0 332 104, example 19).

An additional vector useful for <img file="WO9844137A2_D0001.tif" /> transformation is the binary vector pCIBI O contains a gene encoding kanamycin resistance for selection in plants, T- DNA right and left border sequences and incoφorates sequences from the wide host-range plasmid pRK252 allowing it to replicate in both E. coli and Agrobacterium. Its construction is described by Rothstein et al. (Gene 53: 153-161 (1987)). Various derivatives of pCIBI O have been constructed which incoφorate the gene for hygromycin B phosphotransferase described by Gritz et al. (Gene 25: 179-188 (1983)). These derivatives enable selection of transgenic plant cells on hygromycin only (pCIB743), or hygromycin and kanamycin (pCIB715, pCIB717).

Methods using either a form of direct gene transfer or Agrobacterium-mediaXed transfer usually, but not necessarily, are undertaken with a selectable marker which may provide resistance to an antibiotic (e.g., kanamycin, hygromycin or methotrexate) or a herbicide (e.g., phosphinothricin). The choice of selectable marker for plant transformation is not, however, critical to the invention unless the expression of this resistance and its biochemical activity interferes with the choice of protoxin to toxin conversion chosen for use in creating conditional fertility.

For certain plant species, different antibiotic or herbicide selection markers may be preferred. Selection markers used routinely in transformation include the nptll gene which confers resistance to kanamycin and related antibiotics (Messing &amp; Vierra, Gene 19: 259- 268 (1982); Bevan et al., Nature 304:184-187 (1983)), the bar gene which confers resistance to the herbicide phosphinothricin (White et al., Nucl Acids Res 18:1062 (1990), Spencer et al., TheorAppl Genet 79:625-631 (1990)), the hph gene which confers resistance to the antibiotic hygromycin (Blochinger &amp; Diggelmann, Mol Cell Biol 4: 2929- 2931 ), the dhfrgene, which confers resistance to methotrexate (Bourouis et al., EMBO J. 2: 1009-1104 (1983)), the mannose phosphate isomerase gene, which allows selection on mannose as a carbon source (EP 530 129.WO 94/20627).

One such vector useful for direct gene transfer techniques in combination with selection by the herbicide Basta (or phosphinothricin) is pCIB3064. This vector is based on the plasmid pCIB246, which comprises the CaMV 35S promoter in operational fusion to the E. coli GUS gene and the CaMV 35S transcriptional terminator and is described in the PCT published application WO 93/07278, herein incoφorated by reference. Another useful selectable marker is obtained by operably linking a ubiquitin promoter, a synthetic PAT gene and a nos terminator. Once example of a vector comprising this marker is the plasmid pCIB9804.

An additional transformation vector is pSOG35 which utilizes the E. coli gene dihydrofolate reductase (DHFR) as a selectable marker conferring resistance to methotrexate and the construction of which is described, for example, in WO 95/33818 (example 35)

Another transformation vector is the vector pGL2 (Shimamoto et al. Nature 338, 274- 276 (1989)) which contains the Streptomyces hygromycin phosphotransferase gene (hpt) operably linked to the 35S promoter and 35S terminator sequences.

Transgenic plants can also be identified through the use of a scorable marker. Examples of scorable markers useful in the invention are β-glucuronidase, green fluorescent protein, and the C1 and B-peru regulatory genes of the maize anthocyanin pathway. In addition, transgenic plants expressing a VIP3 protein can be identified by screening them for insecticidal activity without the need for either scorable or selectable markers.

Transformation of maize with a DNA sequence encoding a protein of the VIP3 class, but preferably a VIP3A(c) protein according to any of the above methods can be readily achieved by microprojectile bombardment of either immature zygotic embryos or serially- propagatable Type I embryogenic callus.

For transformation using immature zygotic embryos, ears are self-pollinated and immature zygotic embryos are obtained approximately 10 days later. Approximately eight hundred immature zygotic embryos are divided among different target plates containing a medium capable of inducing and supporting the formation of embryogenic callus. The immature zygotic embryos are transferred immediately to the same medium but containing 12% sucrose. After 5 hours, the immature zygotic embryos are bombarded with a plasmid or piasmids using the PDS-1000/He device from BioRad. The plasmid or plasmids comprise a selectable marker, such as a gene conferring resistance to phosphinothricin,.or a scorable marker, such as green fluorescent protein, and a gene encoding a protein of the VIP3 class prepared for delivery to and expression in maize according to the above description. The plasmid or plasmids are precipitated onto 1 μm gold particles essentially according to the published procedure from BioRad. The particles are delivered using a burst pressure of 1550 psi of helium. Each target plate is shot twice with the plasmid and gold particle preparation. Since in one embodiment of the invention the plasmid or plasmids comprise a chimeric gene coding for resistance to phosphinothricin this substance could be used to select transformed cells in vitro. If used, the selection agent is applied at 10 mg/L on the day of gene delivery and increased to 40 mg/L after approximately one month. The embryogenic callus so obtained may be regenerated in the presence of the selection agent phosphinothricin if the selectable marker is used. Plants are obtained from the selected embryogenic callus lines. The regenerated plants are assayed for resistance to a susceptible insect. All the plants that are resistant to the insect also express the introduced chimeric gene encoding a protein or proteins of the VIP3 class as evidenced by the detection of VIP3 protein in the plant using an ELISA assay. Plants resistant to the insect and expressing the VIP3 protein are transformed.

For transformation of maize using Type I embryogenic callus, the callus is obtained from immature zygotic embryos using standard culture techniques. For gene delivery, approximately 300 mg of the Type I callus is prepared by either chopping with a scalpel blade or by subculturing 3-5 days prior to gene delivery. Prior to gene delivery, the prepared callus is placed onto semi-solid culture medium again containing 12% sucrose. After approximately 4 hours, the tissue is bombarded using the PDS-1000/He Biolistic device from BioRad. The plasmid or plasmids comprise a selectable marker, such as a gene conferring resistance to phosphinothricin, or a scorable marker, such as green fluorescent protein, and a gene encoding a protein of the VIP3 class prepared for delivery to and expression in maize according to the above description. The plasmids are precipitated onto 1 μm gold particles using essentially the standard protocol from BioRad. Approximately 16 hours after gene delivery the callus is transferred to standard culture medium containing 2% sucrose and, if the selectable marker is used, to 1 mg/L phosphinothricin. The callus is subcultured on selection for 8 weeks, after which surviving and growing callus is transferred to standard regeneration medium for the production of plants. The regenerated plants are assayed for resistance to a susceptible insect. All the plants that are resistant to the insect also express the introduced chimeric gene encoding a protein of the VIP3 class as evidenced by the detection of VIP3 protein in the plant using an ELISA assay. Plants resistant to the insect and expressing a protein of the V1P3 class are transformed. SUPPLEMENTAL INSECT CONTROL PRINCIPLES The pesticidal proteins of the invention can be used in combination with Bt δ- endotoxins or other insecticidal proteins to increase insect target range. Furthermore, the use of the VIPs of the present invention, but preferably of the VIP3A(c) protein, in combination with Bt δ-endotoxins or other insecticidal principles of a distinct nature has particular utility for the prevention and/or management of insect resistance.

The various insecticidal crystal proteins from Bacillus thuringiensis have been classified based upon their spectrum of activity and sequence similarity. The classification put forth by Hόfte and Whiteley, Microbiol. Rev. 53: 242-255 (1989) placed the then known insecticidal crystal proteins into four major classes. Generally, the major classes are defined by the spectrum of activity, with the Cry1 proteins active against Lepidoptera, Cry2 proteins active against both Lepidoptera and Diptera, Cry3 proteins active against Coleoptera, and Cry4 proteins active against Diptera.

Within each major class, the δ-endotoxins are grouped according to sequence similarity. The Cry1 proteins are typically produced as 130-140 kDa protoxin proteins which are proteolytically cleaved to produce active toxin proteins about 60-70 kDa. The active portion of the δ-endotoxin resides in the NH₂-terminal portion of the full-length molecule. Hόfte and Whiteley, supta, classified the then known Cry1 proteins into six groups, 1Aa, 1Ab, 1Ac, 1 B, 1C, and 1 D. Since then, proteins classified as Cryl Ea, Cryl Fa, Cry9A, Cry9C and Cry9B have also been characterized.

The spectrum of insecticidal activity of an individual δ-endotoxin from Bacillus thuringiensis tends to be quite narrow, with a given δ-endotoxin being active against only a few insects. Specificity is the result of the efficiency of the various steps involved in producing an active toxin protein and its subsequent ability to interact with the epithelial cells in the insect digestive tract. In one preferred embodiment, expression of VIPs in a transgenic plant is accompanied by the expression of one or more Bt δ-endotoxins. Particularly preferred Bt δ-endotoxins are those disclosed in U.S. application serial no. 07/951 ,715, herein incoφorated by reference.

It is well known that many δ-endotoxin proteins from Bacillus thuringiensis are actually expressed as protoxins. These protoxins are solubilized in the alkaline environment of the insect gut and are proteolytically converted by proteases into a toxic core fragment (Hόfte and Whiteley, Microbiol. Rev. 53: 242-255 (1989)). For δ-endotoxin proteins of the Cryl class, the toxic core fragment is localized in the N-terminal half of the protoxin. It is within the scope of the present invention that genes encoding either the full-length protoxin form or the truncated toxic core fragment of the novel toxin proteins can be used in plant transformation vectors to confer insecticidal properties upon the host plant.

Other insecticidal principles include protease inhibitors (both serine and cysteine types), lectins, α-amylase, peroxidase and cholesterol oxidase. Other VIP genes, such as wp1 A(a) and p2A(a) as disclosed in U.S. Ser. No. 08/463,483 and herein incoφorated by reference, are also useful in the present invention.

This co-expression of more than one insecticidal principle in the same transgenic plant can be achieved by genetically engineering a plant to contain and express all the genes necessary. Alternatively, a plant, Parent 1 , can be genetically engineered for the expression of VIPs. A second plant, Parent 2, can be genetically engineered for the expression of a supplemental insect control principle. By crossing Parent 1 with Parent 2, progeny plants are obtained which express all the genes introduced into Parents 1 and 2.

Recombinant Microorganisms Comprising Genes and Proteins ofthe VIP3 Class

It is recognized that the isolated genes of the present invention which encode a protein of the VIP3 class, but preferably a VIP3A(c) protein, can be transferred into any microbial host and confer their insecticidal properties upon that host. Alternate hosts for the novel genes of the present invention can be selected as suitable for cloning puφoses, for puφoses of characterizing the form and function of the gene or encoded protein, for use as a fermentation host to increase production of the toxin protein, for puφoses of delivering at least one of the toxin proteins more effectively to the target insect pest, or introduction of the novel toxin gene into insect pathogens such as baculovirus (a nuclear polyhedrosis virus, e.g. Autographica califomica) to improve their effectiveness.

It is envisioned that said alternate host would be applied to the environment or plants or animals for insect control. Microorganism hosts may be selected which are known to occupy the "phytosphere" (phylloplane, phyllosphere, rhizosphere, and/or rhizoplana) of one or more crops of interest. These microorganisms are selected so as to be capable of successfully competing in the particular environment with the wild-type microorganisms, provide for stable maintenance and expression of the gene expressing the polypeptide pesticide, and, desirably, provide for improved protection of the pesticide from environmental degradation and inacfrvation. Such microorganisms include bacteria, algae, and fungi. Of particular interest are microorganisms, such as bacteria, e.g., Bacillus, Caulobacter, Agmenellum, Pseudomonas, Erwinia, Serratia, Klebsiella, Xanthomonas, Streptomyces, Rhizobium, Rhodopseudomonas, Methylius, Agrobactenum, Acetobacter, Lactobacillus, Arthrobacter, Azotobacter, Leuconostoc, and Alcaligenes; fungi, particularly yeast, e.g., Saccharomyces, Cryptococcus, Kluyveromyces, Spombolomyces, Rhodotorula, and Aureobasidium. Of particular interest are such phytosphere bacterial species as Bacillus spp., Pseudomonas syringae, Pseudomonas fluorescens, Serratia marcescens, Acetobacter xylinum, Agrobacteria, Rhodopseudomonas spheroides, Xanthomonas campestris, Rhizobium melioti, Alcaligenes entrophus, Clavibacter xyli and Azotobacter vinlandii; and phytosphere yeast species such as Rhodotorula rubra, R. glutinis, R. marina, R. aurantiaca, Cryptococcus albidus, C. diffiuens, C. laurentii, Saccharomyces rosei, S. pretoriensis, S. cerevisiae, Spombolomyces rosues, S. odorus, Kluyveromyces veronae, and Aureobasidium pollulans. Of particular interest are the pigmented microorganisms.

Suitable host cells, where the pesticide-containing cells will be treated to prolong the activity of the toxin in the cell when the then treated cell is applied to the environment of the target pest(s), may include either prokaryotes or eukaryotes, normally being limited to those cells which do not produce substances toxic to higher organisms, such as mammals. However, organisms which produce substances toxic to higher organisms could be used, where the toxin is unstable or the level of application sufficiently low as to avoid any possibility of toxicity to a mammalian host. As hosts, of particular interest will be the prokaryotes and the lower eukaryotes, such as fungi. Illustrative prokaryotes, both Gram-negative and -positive, include Enterobacteriaceae, such as Escherichia, Erwinia, Shigella, Salmonella, and Proteus; Bacillaceae; Rhizobiceae, such as Rhizobium; Spirillaceae, such as photobacterium, Zymomonas, Serratia, Aeromonas, Vibrio, Desulfovibrio, Spirillum; Lactobacillaceae; Pseudomonadaceae, such as Pseudomonas and Acetobacter, Azotobacteraceae and Nitrobacteraceae. Among eukaryotes are fungi, such as Phycomycetes and Ascomycetes, which includes yeast, such a Saccharomyces and Schizosaccharromyces; and Basidiomycetes yeast, such as Rhodotorula, Aureobasidium, Spombolomyces, and the like.

Characteristics of particular interest in selecting a host cell for puφoses of production include ease of introducing the protein gene into the host, availability of expression systems, efficiency of expression, stability of the protein in the host, and the presence of auxiliary genetic capabilities. Characteristics of interest for use as a pesticide microcapsule include protective qualities for the pesticide, such as thick cell walls, pigmentation, and intracellular packaging or formation of inclusion bodies; leaf affinity; lack of mammalian toxicity; attractiveness to pests for ingestion; ease of killing and fixing without damage to the toxin; and the like. Other considerations include ease of formulation and handling, economics, storage stability, and the like.

Host organisms of particular interest include yeast, such as Rhodotorula sp., Aureobasidium sp., Sacchammyces sp., and Spombolomyces sp.; phylloplane organisms such as Pseudomonas sp., Erwinia sp. and Flavobacterium sp.; or such other organisms as Escherichia, LactoBacillus sp., Bacillus sp., and the like. Specific organisms include Pseudomonas aeurginosa, Pseudomonas fluorescens, Sacchammyces cerevisiae, Bacillus thuringiensis, Escherichia coli, Bacillus subtilis, and the like.

A number of ways are available for introducing a gene expressing the pesticidal protein into the microorganism host under conditions which allow for stable maintenance and expression of the gene. For example, expression cassettes can be constructed which include the DNA constructs of interest operably linked with the transcriptional and translational regulatory signals for expression of the DNA constructs, and a DNA sequence homologous with a sequence in the host organism, whereby integration will occur, and/or a replication system which is functional in the host, whereby integration or stable maintenance will occur.

Transcriptional and translational regulatory signals include but are not limited to promoter, transcriptional initiation start site, operators, activators, enhancers, other regulatory elements, ribosomal binding sites, an initiation codon, termination signals, and the like. See, for example, US Patent 5,039,523; US Patent No. 4,853,331 ; EPO 0480762A2; Sambrook et al. supra; Molecular Cloning, a Laboratory Manual, Maniatis et al. (eds) Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1982); Advanced Bacterial Genetics, Davis etal. (eds.) Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1980); and the references cited therein.

The novel genes or recombinant forms thereof can be transformed into such alternate hosts using a variety of art recognized methods. One such preferred method is electroporation of microbial cells, as described, for example, by the method of Dower (U.S. Patent No. 5,186,800). Another preferred method is that of Schurter et al. (Mol. Gen. Genet. 218: 177-181 (1989)), which is also disclosed in U.S. Serial No. 07/353,565 which is incoφorated herein in its entirety. Genes encoding the VIP3 class of proteins can be introduced into microorganisms that multiply on plants (epiphytes) or in plants (endophytes) to deliver proteins of the VIP3 class to potential target pests. Many bacterial species are capable of living in the vascular tissues of plants. Most of these endophytes and epiphytes appear to have little physiological impact on plant growth and productivity.

Root colonizing bacteria, for example, can be isolated from the plant of interest by methods known in the art. Specifically, a Bacillus cereus strain which colonizes roots could be isolated from roots of a plant ( for example see J. Handelsman, S. Raffel, E. Mester, L. Wunderlich and C. Grau, Appl. Environ. Microbiol. 56:713-718, (1990)). V7p3 genes can also be introduced into a root colonizing Bacillus cereus by standard methods known in the art. Specifically, a gene encoding a protein of the VIP3 class derived from strain AB88 can be introduced into a root colonizing Bacillus cereus by means of conjugation using standard methods (J. Gonzalez, B. Brown and B. Carlton, Proc. Natl. Acad. Sci. 79:6951-6955, (1982)).

Also, the novel genes of the invention can be introduced into the root colonizing Bacillus by means of electro-transformation. For example, vp3A(a) can be cloned into a shuttle vector, for example, pHT3101 (D. Lereclus et al., FEMS Microbiol. Letts., 60:211-218 (1989)). The shuttle vector pHT3101 containing the coding sequence can then be transformed into the root colonizing Bacillus by means of electroporation (D. Lereclus et al. 1989, FEMS Microbiol. Letts. 60:211-218). It is also possible to use the cotton colonizing Bacillus megaterium.

Another example is afforded by the endophyte Clavibacter xyli, which is from a genus/species known contain phytopathogenic bacteria which cause plant stunting. This bacterium can grow to very high levels in the vascular system of plants. A δ-endotoxin was introduced into this endophyte, which when inoculated into a plant, provided good control of corn borer. Other endophytes are also known.

Expression systems can be designed so that VIP3 proteins are secreted outside the cytoplasm of gram negative bacteria, E. coli, for example. Advantages of having VIP3 proteins secreted are (1) it can increase the level of VIP3 protein expressed and (2) can aid in efficient purification of VIP3 protein.

VIP3 proteins can be made to be secreted in E. coli, for example, by fusing an appropriate £. coli signal peptide to the amino-terminal end of the VIP3 signal peptide or replacing the VIP3 signal peptide with the E. coli signal peptide. Signal peptides recognized by E. coli can be found in proteins already known to be secreted in E. coli, for example the OmpA protein (J. Ghrayeb, H. Kimura, M. Takahara, Y. Masui and M. Inouye, EMBO J., 3:2437-2442 (1984)). OmpA is a major protein of the E. coli outer membrane and thus its signal peptide is thought to be efficient in the translocation process. Also, the OmpA signal peptide does not need to be modified before processing as may be the case for other signal peptides, for example lipoprotein signal peptide ( G. Duffaud, P. March and M. Inouye, Methods in Enzymology, 153:492 (1987)).

Specifically, unique BamHI restriction sites can be introduced at the amino-terminal and carboxy-terminal ends of the VIP coding sequences using standard methods known in the art. These BamHI fragments can be cloned, in frame, into the vector plN-lll-ompA1 , A2 or A3 (J. Ghrayeb, H. Kimura, M. Takahara, H. Hsiung, Y. Masui and M. Inouye, EMBO J., 3:2437-2442 (1984)) thereby creating ompANIP fusion gene which is secreted into the periplasmic space. The other restriction sites in the polylinker of plΝ-lll-ompA can be eliminated by standard methods known in the art so that the VIP3 amino-terminal amino acid coding sequence is directly after the ompA signal peptide cleavage site. Thus, the secreted VIP3 sequence in E. coli would then be identical to the native VIP3 sequence.

When the VIP3 native signal peptide is not needed for proper folding of the mature protein, such signal sequences can be removed and replaced with the ompA signal sequence. Unique BamHI restriction sites can be introduced at the amino-termini of the proprotein coding sequences directly after the signal peptide coding sequences of VIP3 and at the carboxy-termini of VIP3 coding sequence. These BamHI fragments can then be cloned into the plΝ-lll-ompA vectors as described above.

General methods for employing the strains of the invention in pesticide control or in engineering other organisms as pesticidal agents are known in the art. See, for example US Patent No. 5,039,523 and EP 0480762A2.

VIP3 can be fermented in a bacterial host and the resulting bacteria processed and used as a microbial spray in the same manner that Bacillus thuringiensis strains have been used as insecticidal sprays. In the case of a VIP3 which is secreted from Bacillus, the secretion signal is removed or mutated using procedures known in the art. Such mutations and/or deletions prevent secretion of the VIP3 protein(s) into the growth medium during the fermentation process. The VIP3 proteins are retained within the cell and the cells are then processed to yield the encapsulated VIP3 protein. Any suitable microorganism can be used for this puφose. Psuedomonas has been used to express Bacillus thuringiensis endotoxins as encapsulated proteins and the resulting cells processed and sprayed as an insecticide. (H. Gaertner et al. 1993, In Advanced Engineered Pesticides, L. Kim ed.)

Various strains of Bacillus thuringiensis are used in this manner. Such Bt strains produce endotoxin protein(s) as well as VIP3. Altematively, such strains can produce only VIP3. A sporulation deficient strain of Bacillus subtilis has been shown to produce high levels of the Cry3A endotoxin from Bacillus thuringiensis (Agaisse, H. and Lereclus, D., "Expression in Bacillus subtilis of the Bacillus thuringiensis CrylllA toxin gene is not dependent on a sporulation-specific sigma factor and is increased in a spoOA mutanf , J. Bacteriol., 176:4734-4741 (1994)). A similar spoOA mutant can be prepared in Bacillus thuringiensis and used to produce encapsulated VIP3 which are not secreted into the medium but are retained within the cell.

Target crops to be protected within the scope of the present invention comprise, e.g., the following species of plants:

cereals (wheat, barley, rye, oats, rice, sorghum and related crops), beet (sugar beet and fodder beet), forage grasses (orchardgrass, fescue, and the like), drupes, pomes and soft fruit (apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries and blackberries), leguminous plants (beans, lentils, peas, soybeans), oil plants (rape, mustard, poppy, olives, sunflowers, coconuts, castor oil plants, cocoa beans, groundnuts), cucumber plants (cucumber, marrows, melons) fiber plants (cotton, flax, hemp, jute), citrus fruit (oranges, lemons, grapefruit, mandarins), vegetables (spinach, lettuce, asparagus, cabbages and other Brassicae, onions, tomatoes, potatoes, paprika), lauraceae (avocados, carrots, cinnamon, camphor), deciduous trees and conifers (e.g. linden-trees, yew-trees, oak-trees, alders, poplars, birch-trees, firs, larches, pines), or plants such as maize, tobacco, nuts, coffee, sugar cane, tea, vines, hops, bananas and natural rubber plants, as well as ornamentals (including composites). The microorganisms which have been genetically altered to contain the pesticidal gene and protein may be used for protecting agricultural crops and products from pests. In one aspect of the invention, whole, i.e., unlysed, cells of a toxin (pesticide)-producing organism are treated with reagents that prolong the activity of the toxin produced in the cell when the cell is applied to the environment of target pest(s). Alternatively, the pesticides are produced by introducing a heterologous gene into a cellular host. Expression of the heterologous gene results, directly or indirectly, in the intracellular production and maintenance of the pesticide. These cells are then treated under conditions that prolong the activity of the toxin produced in the cell when the cell is applied to the environment of target pest(s). The resulting product retains the toxicity of the toxin. These naturally encapsulated pesticides may then be formulated in accordance with conventional techniques for application to the environment hosting a target pest, e.g., soil, water, and foliage of plants. See, for example EPA 0192319, and the references cited therein.

The active ingredients of the present invention are normally applied in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession, with other compounds. These compounds can be both fertilizers or micronutrient donors or other preparations that influence plant growth. They can also be selective herbicides, insecticides, fungicides, bactericides, nematicides, mollusicides or mixtures of several of these preparations, if desired, together with further agriculturally acceptable carriers, surfactants or application-promoting adjuvants customarily employed in the art of formulation. Suitable carriers and adjuvants can be solid or liquid and correspond to the substances ordinarily employed in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, binders or fertilizers.

Preferred methods of applying an active ingredient of the present invention or an agrochemical composition of the present invention which contains at least one of the pesticidal proteins produced by the bacterial strains of the present invention are leaf application, seed coating and soil application. The number of applications and the rate of application depend on the intensity of infestation by the corresponding pest.

Entomocidal Compositions Comprising a Recombinant Bacillus thuringiensis Strain

The present invention further provides an entomocidal composition comprising a recombinant Bacillus thuringiensis strain containing at least one of the novel toxin genes in recombinant form, or derivatives or mutants thereof, together with an agricultural adjuvant such as a carrier, diluent, surfactant or application-promoting adjuvant. The composition may also contain a further biologically active compound selected from fertilizers, micronutrient donors, plant growth preparations, herbicides, insecticides, fungicides, bactericides, nematicides and molluscicides and mixtures thereof. The composition may comprise from 0.1 to 99% by weight of a recombinant Bacillus thuringiensis strain containing at least one of the novel genes in recombinant form, or the derivatives or mutants thereof, from 1 to 99.9% by weight of a solid or liquid adjuvant, and from 0 to 25% by weight of a surfactant. The recombinant Bacillus thuringiensis strain containing at least one of the novel genes in recombinant form, or the composition containing it, may be administered to the plants or crops to be protected together with certain other insecticides or chemicals (1993 Crop Protection Chemicals Reference, Chemical and Pharmaceutical Press, Canada) without loss of potency. It is compatible with most other commonly used agricultural spray materials but should not be used in extremely alkaline spray solutions. It may be administered as a dust, a suspension, a wettable powder or in any other material form suitable for agricultural application.

A recombinant Bacillus thuringiensis strain containing at least one of the novel genes in recombinant form is normally applied in the form of entomocidal compositions and can be applied to the crop area or plant to be treated, simultaneously or in succession, with further biologically active compounds. These compounds may be both fertilizers or micronutrient donors or other preparations that influence plant growth. They may also be selective herbicides, insecticides, fungicides, bactericides, nematicides, molluscicides or mixtures of several of these preparations, if desired together with further carriers, surfactants or application-promoting adjuvants customarily employed in the art of formulation. Suitable carriers and adjuvants can be solid or liquid and correspond to the substances ordinarily employed in formulation technology, e.g. natural or regenerated mineral substances, solvents, dispersants, wetting agents, tackifiers, binders or fertilizers. The formulations, i.e. the entomocidal compositions, preparations or mixtures containing the recombinant Bacillus thuringiensis strain containing the novel gene in recombinant form as an active ingredient or combinations thereof with other active ingredients, and, where appropriate, a solid or liquid adjuvant, are prepared in known manner, e.g., by homogeneously mixing and/or grinding the active ingredients with extenders, e.g., solvents, solid carriers, and in some cases surface-active compounds (surfactants).

Solvents, carriers, surfactants, surface active compounds, etc that are customarily employed in the art of formulation and can be suitably used within the present invention are disclosed, for example, in WO 96/10083.

Another particularly preferred characteristic of an entomocidal composition of the present invention is the persistence of the active ingredient when applied to plants and soil. Possible causes for loss of activity include inactivation by ultra-violet light, heat, leaf exudates and pH. For example, at high pH, particularly in the presence of reductant, δ- endotoxin crystals are solubilized and thus become more accessible to proteolytic inactivation. High leaf pH might also be important, particularly where the leaf surface can be in the range of pH 8-10. Formulation of an entomocidal composition of the present invention can address these problems by either including additives to help prevent loss of the active ingredient or encapsulating the material in such a way that the active ingredient is protected from inactivation. Encapsulation can be accomplished chemically (McGuire and Shasha, 1992) or biologically (Barnes and Cummings, 1986). Chemical encapsulation involves a process in which the active ingredient is coated with a polymer while biological encapsulation involves the expression of the δ-endotoxin genes in a microbe. For biological encapsulation, the intact microbe containing the δ-endotoxin protein is used as the active ingredient in the formulation. The addition of UV protectants might effectively reduce irradiation damage. Inactivation due to heat could also be controlled by including an appropriate additive.

The entomocidal compositions usually contain 0.1 to 99%, preferably 0.1 to 95%, of a recombinant Bacillus thuringiensis strain containing at least one of the novel genes in recombinant form, or combination thereof with other active ingredients, 1 to 99.9% of a solid or liquid adjuvant, and 0 to 25%, preferably 0.1 to 20%, of a surfactant. Whereas commercial products are preferably formulated as concentrates, the end user will normally employ dilute formulations of substantially lower concentration. The entomocidal compositions may also contain further ingredients, such as stabilizers, antifoams, viscosity regulators, binders, tackifiers as well as fertilizers or other active ingredients in order to obtain special effects.

Methods of Controlling Insects

In view of the above description of the invention, it is apparent that there are several methods by which insects may be controlled using proteins of the VIP3 class as an insecticidal principle, either alone or in combination with supplementary insect control principles such as δ-endotoxins. Any method of delivering a VIP3 protein for ingestion by a susceptible insect will result in the control of that insect.

In one embodiment of the invention, plants are transformed with a gene encoding a protein of the VIP3 class. Expression of the protein may occur at any time during growth and development of the plant, depending on the nature of the insect to be controlled. For example, a protein of the VIP3 class can, according to the invention, be expressed in roots, stems, leaves, seeds, pollen, etc. This provides the advantage of expressing the protein only in those cells or tissues upon which the target insect feeds. Feeding the cells or tissues of a plant expressing VIP3 protein to a susceptible insect will result in the control of that insect. In one embodiment of the invention, a VIP3 protein is expressed in the stem or stalk of a plant in order to control black cutworm. The plants may be grown under either field or greenhouse conditions. Seed containing a VIP3 protein can also be protected against insect damage when in storage.

EXAMPLES Examples 16 to 18 on pages 73 to 82 of WO 96/10083 describe the isolation and biological characterization of Bacillus thuringiensis strains AB88 and AB424, the purificatin and characterization of a VIP3A(a) protein, the cloning of vip3A(a) and vip3A(b) genes, and the identification of new vip genes by hybridization. Said Examples are incoφorated herein in their entirety by reference. The following examples further describe the materials and methods used in carrying out the invention and the subsequent results. They are offered by way of illustration, and their recitation should not be considered as a limitation of the claimed invention.

Example 1: Presence of wp3-like genes and VIP3-like proteins in Bacillus isolates

Bacillus isolates other than AB88 have demonstrated insecticidal activity against Lepidopteran larvae when spent culture supematants were tested. Some isolates which were active against black cutworm were analyzed for the presence of v/p3-like genes and for the production of VIP3-like proteins.

A standard PCR analysis was used to determine whether the black cutworm-active Bacillus isolates contained a vp3-like gene. Using the PCR primer pair GW110 (5'-CGA TTA ATG TTG GCC TC-3"; SEQ ID NO:17) and GW111 (5'-CAT TAG CAT CTC CGG ACA CAG-3'; SEQ ID NO:18) it was determined that all of the black cutworm active isolates produced a 728 bp wp3 gene product which was equal to the size produced by the type strain, AB88. One Bacillus isolate, AB51 , which was not active against black cutworm, . produced the same size vipZ product. None of the other non-black cutworm active Bacillus isolates produced a vipZ PCR product. Analysis of VIP3 protein production was done using a standard westem blot procedure. Antibodies raised against the VIP3A(a) protein described in the above example were used to detect immunoreactive proteins. Aliquots of cell free culture supematants from sporulated cultures were run on SDS-PAGE gels using standard methods. Standard westem blotting procedures were then carried out to determine the presence of VIP3-like proteins. All of the Bacillus isolates which had a 728 bp PCR product and were active against black cutworm produced an 80 kDa protein which was immunoreactive to the VIP3A(a) antibody. The AB51 isolate which had the correct size vip3 PCR product but was not active against black cutworm produced an immunoreactive protein which was truncated suggesting this may be the reason no biological activity against black cutworm was observed.

Example 2: Characterization of Bacillus thuringiensis Strain AB51 Containing a vip3-\\ke Gene

A B. thuringiensis strain, designated AB51 , was shown to contain proteins of the VIP3 class by western analysis using rabbit polyclona! anti-Vip3A(a) antibodies. The p3-like gene was cloned into pKS which created pCIB7112. This gene was given the designation wp3A(c). The DNA sequence for p3A(c) is disclosed in SEQ ID NO:5 and the encoded protein sequence is disclosed in SEQ ID NO:6. The VIP3A(c) protein is 746 amino acids long, 43 amino acids shorter than its VIP3A(a) and VIP3A(b) homoiogues.

Example 3: Development of Antibodies to VIP3A(a) Protein

Antiserum against purified Vip3A(a) insecticidal protein was produced in rabbits and goats. For rabbits, nitrocellulose-bound protein (50 μg) was dissolved in DMSO, emulsified with Freund's complete adjuvant (Difco) and injected subcutaneously twice a month for three months. For goats, active soluble pure Vip3A protein (300 μg) was injected intramuscularly twice a month for three month. They were bled 10 days after the second and third injection and the serum was recovered from the blood sample (Harlow, E. and Lane, D. Antibodies: A Manual Laboratory, Cold Spring Harbor Lab. Press, NY, 1988). The antiserums were then fractionated by affinity chromatography utilizing staphylococcal protein A, and the resulting IgG fraction was further purified by filtering through a column containing immobilized-E. coli lysate (Yu, C.G. et al. Appl. Environ. Microbiol. 63:532-536 (1997)). The rabbit and goat antiserums were characterized analyzing the Vip3A(a) protein by western blot. Proteins were separated by SDS/PAGE and transferred to nitrocellulose. Nitrocellulose blots were blocked in 20 mM Tris-HCl, pH 7.5/0.15 M NaCI/0.02% NaNa/5% nonfat dry milk. Blots were developed by using either rabbit raised or goat-raised anti- Vip3A(a) antibodies at a concentration of 200 ng/ml or 100 ng/ml respectively. Alkaline phosphatase-conjugated goat antirabbit IgG or rabbit antigoat antiserum were used as secondary antibodies at a concentration of 1 μg ml (Kirkegaard &amp; Perry Laboratories, Inc.). Bromochloroindolyl-phosphate and nitroblue tetrazolium were used as substrate for the alkaline phosphatase reaction. Both anti-Vip3A(a) antibodies, the rabbit and the goat raised, are polyclonal. The anti-Vip3A(a) antibodies obtained from goat have a higher titer than the ones obtained from rabbits. In the experimental approach, anti-Vip3A(a) antibodies from rabbit should be used at a dilution 1/500 from the original serum (200 ng ml). By comparison, the anti-Vip3A(a) antibodies obtained from goat can be diluted up to 1/2000 (100 ng/ml) from the original serum. While the rabbit raised antibodies only recognize the N- terminal portion of the Vip3A(a) protein, the antibodies obtained from goats react with epitopes present throughout the full length of the Vip3A(a) protein.

Example 4: Construction of Plant Expression Cassettes

Plant expression cassettes consist of promoters that can drive the expression of a coding sequence either constitutively or in a tissue-specific manner, the coding sequences to be expressed and the termination sequences which allow the polyadenylation of the mRNA and its proper translation.

The promoters selected in the DNA constructs of the present invention includes constitutive promoters such as the one from the maize ubiquitin gene (Christensen et al. Plant Mol. Biol. 12:619-632, 1989) (pCIB8029, Figure 4; pCIB8055, Figure 5; pCIB9806, Figure 6), and tissue specific promoters such as those from the maize methalothionein-like gene (de Framond, A. FEBS 290:103-106, 1991) (pCIB8030, Figure 7; pCIB8056, pCIB9805) which provides a root-preferred expression, from the maize PEPC gene (Hudspeth, R.L and Grula, J.W. Plant Mol. Biol. 12:579-589, 1989) (pCIB5535, Figure 8; pCIB9807) which provides a green-tissue specific expression, and from the barley nonspecific lipid transfer protein LTP4 (pCIB9819, Figure 9)(Molina, A. and Garcia-Olmedo, F. Plant J. 4:983-991 , 1993) which provides a stem-preferred expression. All constructs used in the present invention contain the terminator sequence derived from the 35S CaMV and the intron 9 derived from the maize PEPC gene for enhancing gene expression puφoses. The plasmids pCIB8029, pCIB8055, and pCIB9806 contain the intron#1 of the maize ubiquitin gene placed between the maize ubiquitin promoter and the v/p3A(a) gene. The construct comprising the encoding sequence of the <img file="WO9844137A2_D0002.tif" /> gene, the intron#9 and the 35S terminator sequence was engineered into the recipient plasmid bearing the different promoters as double digests BamH\-EcoR\.

The plant expression cassettes were used as such in the plant transformation experiments, or they were linearised by using restriction enzymes that cut in the Amp^R gene of the backbone plasmid. In some experiments, fragments comprising the promoter, gene of interest, intron and terminator were isolated from the rest of the plasmid backbone by restriction digestion and fragment purification. In these cases fragment purification proceeded as follows: 500 ug of DNA is digested with the appropriate enzyme and separated on a 0.8% agarose gel. The fragment of interest is identified, cut out from the gel and purified using a Durapore Millipore filter (0.45 micron). The filtrate containing the fragment is precipitated with sodium acetate and ethanol. The fragment is resuspended in TE and used in transformation experiments.

Example 5: Insecticidal activity of maize plants expressing VIP3A(a)

Maize plants expressing VIP3A(a) protein were tested for insecticidal effects on the insect species listed in the table below by the following procedure. One to four 4 cm sections were cut from leaves of transgenic and control maize plants. Each leaf piece was placed on a moistened filter disc in a 50 X 9 mm petri dish. Five neonates of the species being tested were placed on each leaf piece giving a total of 5-20 larvae tested for each plant. The Petri dishes were incubated at 30° C in the dark. Mortality was scored after 48-72 hours. Results are shown in Table 16.

Table 16.

Percent mortality

Insect species tested VIP3A(a) Control

Maize Pests

Black cutworm (Ag tis ipsilon) 100 0

Fall armyworm (Spodoptera frugiperda) 100 0

Sugarcane borer (Diatrea saccharalis) 100 0

Southwestern corn borer (Diatraea grandiosella) 100 0

Corn earworm (Helicoveφa zea) 100 10

Mediterranean corn borer (Sesamia nonagmides ) 100 15 Other Lepidopteran Pests

Beet armyworm (S. exigua) 100 0

Yellow striped armyworm (S. omithogalli) 100 0

Cabbage looper (Trichoplusia ni) 100 20

Example 6: Expression of p3A(a) in Maize Plants

Transformation of maize elite Ciba inbred lines CG00526 and 2154 with the Vip3 gene was achieved using particle bombardment of Type I callus tissue. For transformation using Type I embryogenic callus, the callus was obtained from zygotic embryos using standard culture techniques and subcultured 1-2 days prior to bombardment. Callus tissue was prepared for bombardment by placing -20, 3-5mm diameter pieces arranged in a ring shape onto culture medium containing 12% sucrose. Callus tissue was placed onto this media for four hours prior to bombardment. DNA used for transformation of maize callus was either circular plasmid DNA, linear plasmid DNA, or purified DNA fragments containing the Vip3 gene under control of various plant promoters. In experiments where a selectable agent was used, the gene allowed resistance to phosphinothricin or allowed for growth in the presence of mannose. Plasmids or DNA fragments isolated by filtration were precipitated onto 0.3 urn gold particles according to published procedures from BioRad Laboratories, Hercules, CA. Gold particles were delivered using a burst pressure of 650 psi of helium. Each target plate was shot twice with the DNA coated particles. Sixteen to twenty hours after bombardment the CG00526 callus was transferred to standard culture maintenance media. Seven days post-bombardment the tissue was transferred to media containing the selection agent, Basta at a concentration of 100 mg/L. Basta is a commercial formulation of glufosinate ammonium produced by Hoechst. Callus of 2154 was kept on 12% sucrose for 1-7 days after bombardment and transferred to standard culture media containing 20-30 mg L Basta at day 7. The 2154 and CG00526 callus was subcultured in the presence of 30 or 100 mg/L Basta, respectively, for eight weeks. Tissue surviving selection was subcultured onto lower levels of Basta (5-40 mg/L) for a period of approximately five to ten weeks to allow for tissue bulk-up and then transferred to a standard regeneration media with no selection for the production of plants. Commonly, 12% of the callus pieces bombarded produced transformed callus that survived Basta selection. Individual transformed calli would typically be regenerated to produce 20-30 plants.

Events were generated from experiments where no selection was used. In these experiments the callus was grown for a period of 9-10 weeks on maintenance media prior to transf erring to regeneration media. Event 1337 is an example of a transformed VIP3 event derived from a transformation experiment with no selectable or scorable marker by screening plants for insecticidal activity.

Transformed calli were also generated from experiments where mannose selection was used. In these transformations the phosphomannose isomerase gene under control of the maize ubiquitin promoter of pCIB9818 was bombarded with the Vip3 gene. Mannose at 0.5-1.5% was included in the maintenance media for a period of twelve weeks and not included in the regeneration media.

Transgenic plants were evaluated for VIP3A(a) protein expression by insect bioassay and ELISA assay. Leaf pieces were removed from 2-4 leaf stage plants for evaluation using both black cutworm and fall army worm bioassays. Bioassays were done using ten newly hatched larvae placed in dishes with leaf pieces. Percent mortality was calculated at 72 hours. Tissues from transgenic plants were also assayed by ELISA using standard protocols to quantitate Vip3 protein levels in different plant tissues. Plant tissue was extracted and Table 17 provides representative events generated and their corresponding of insect bioassay results.

Transgenic maize plants were transformed with various plasmids containing the Vip3 gene under control of various promoters such as the maize PEP-carboxylase promoter (PEPC), the maize ubiquitin promoter (Ubi), and the maize metallothionein-like promoter (MTL). The selectable marker gene was the PAT gene under control of the maize ubiquitin promoter in pUBIAC. Representative events listed in Table 17 show the events produced with different plasmids or DNA fragments derived from plasmids. DNA fragments were generated using restriction enyzme digestions and size fractionated using electrophoresis in 0.8% agarose gels. The DNA fragments were excised from the gels, frozen, crushed and purified by filtration through 0.45 micron DuraPore Millipore filters followed by ethanol precipitation. Transformed maize events were generated with circular plasmid DNA of pCIB5535 containing the Vip3 gene under control of the maize PEPC promoter. Events were also transformed with linear plasmid DNA of pCIB5535 and pCIB8029 containing the Vip3 gene under control of the maize ubiquitin promoter. Additional events were produced by bombarding purified DNA restriction enzyme fragments containing just the Vip3 gene with promoter. Fragments corresponding to the Vip3 gene include: a 4906bp EcoRI/Hindlll fragment from pCIB5535 with the maize PEPC promoter; a 5142bp Kpnl/Hindlll fragment from pCIB8030 with the MTL promoter; a 4597bp Kpnl/Hindlll fragment of pCIB8029 with the maize ubiquitin promoter; a 4818bp Hindlll fragment of pCIB8055 with the maize ubiqutin promoter; a 5364 Hindlll fragment of pCIB8056 with the MTL promoter; a 5964 AscI fragment of pCIB9805 with the MTL promoter; a 5418bp AscI fragment of pCIB9806 with the maize ubiqutin promoter; and a 5727bp AscI fragment of pCIB9807 with the maize PEPC promoter.

Table 17

Mortality (%)

Event No. Plasmid Used Chimeric Gene Fall Armyworm Black Cutworm

891 pCIB5535 PEPC:wp3A(a) 100 100

906 pCIB5535 and PEPC:v/p3A(a) 100 100 pCIB8029 and

Ubi: p3A(a)

946 pCIB5535 and PEPC: p3A(a) 100 100 pCIB8030 and MTL:wp3A(a)

Example 7: Insecticidal activity of maize plants containing Vip3 and Bt δ-endotoxins

VIP3A(a) has little activity against European corn borer (ECB). To make plants with broad spectrum lepidopteran control, maize plants containing a p3A(a) gene were crossed with maize plants containing a ctyl B, which is active against ECB. Progeny from the crosses were bioassayed against ECB and fall armyworm (FAW) as described in Example 1. Results are shown in Table 18. Approximately 34 % of the progeny were not active against either species, 15.4 % were active only on ECB, 23.1 % were active only on FAW and 27.9 % were active against both species. Plants active against both species contained both VIP3A(a) and Cry1 B protein. Similar results are obtained using other Bt δ-endotoxins, particularly CrylAb or Cry9C.

Table 18

Cross % ECB % FAW % ECB &amp; FAW % not active active active active

VIP3A(a) X Cry1 B 15.4 23.1 27.9 34.6 Example 8: VIP3A(a^ Lvses the Midαut Epithelial Cells of Susceptible Insects

Feeding and gut clearance studies. The temporal sequence of symptoms following the ingestion of VIP3A(a)-containing diet by second-instar black cutworm (BCW) larvae, a susceptible insect, were recorded from the time of initial administration until larval death. Larvae exposed to control diet showed active feeding followed by uninterrupted gut parastalsis. In contrast, the addition of VIP3A(a) protein in the diet had a significant effect on feeding behavior. When added at concentrations as low as 4 ng per cm², the larvae fed on and off during periods of 10-20 min. The presence of blue color in their guts indicated feeding but the clearance of the gut content was dramatically affected as judged by the deceased number of frass. With 4 ng of VIP3A(a) per cm² added to the diet, larval development was significantly impaired after a 48 h incubation period but no mortality was observed. At concentrations of 40 ng of Vip3A(a) per cm², the larvae suffered gut paralysis upon ingestion of minute amounts of diet and no frass could be seen indicating an almost complete lack of gut clearance. Under this condition, ca. 50% mortality was recorded after 48 hr. When concentrations higher than 40 ng of VIP3A(a) per cm² were used, the larvae were moribund after only a few bites, with no frass and mortality rates approaching 100%. When similar experiments were conducted with fall armyworm, also a susceptible insect, similar behavioral patterns were observed. In contrast, European corn borer did not alter its feeding behavior when VIP3A(a) protein was added to the diet even at concentrations as high as 400 ng of VIP3A(a) per cm².

Histological observations of the effects of the Vip3A(a) protein. Histopathological observations on the effects of the VIP3A(a) protein on BCW were conducted on second and third instar larvae which had been fed a diet containing VIP3A(a). Analysis of BCW gut cross-sections showed extensive damage to the midgut epithelium indicating that the midgut tissue is a primary site of action of the Vip3A(a) protein. No damage was discernible in the foregut and hindgut. Midgut epithelial cells from untreated larvae were closely associated with one another showing no evidence of damage. Sections from larvae that had been fed for 24 h with diet containing Vip3A(a) showed that distal ends of the epithelium columnar cells had become distended and bulbous. Although the goblet cells exhibited some morphological alterations, they did not show signs of damage at this stage. Degeneration of the epithelium columnar cells continued such that, after 48 h of ingesting Vip3A(a)-containing diet, the lumen was filled with debris of disrupted cells. The goblet cells also exhibited signs of damage after 48 h, but both types of cells were still attached to the basement membrane. Black cutworm larvae were dead at 72h and desquamation of the epithelial layer was complete. While a similar histopathology was observed for fall armyworm, European corn borer did not exhibit any tissue damage under similar experimental conditions.

In vivo immunolocalization of the Vip3A(a) protein. Third instar larvae of black cutworm and European corn borer fed on artificial diet supplemented with 100-200 ng of VIP3A(a) per cm² were used for immunocytochemical characterization of the VIP3A(a) binding to midgut sections. The bound VIP3A(a) was visualized using rabbit anti-VIP3A(a) antibodies previously purified through protein A sepharose and E. coli immobilized columns (Yu, C.G. et al. Appl. Environ. Microbiol. 63:532-536, 1997). VIP3A(a) binding was detected in midgut epithelium of black cutworm, while showing no binding to European corn borer midguts. Midgut sections from black cutworm larvae fed with control diet showed no VIP3A(a) binding. The VIP3A(a) binding seems to be specifically associated to the apical microvilli and it is mostly associated to the columnar cells, with no detectable signal in the goblet cells.

Example 9: VIP3A(a) and VIP3A(b Induce Apoptosis in Insect Cells

VIP3A(a) and VIP3A(b) were shown to be a apoptosis inducing protein arose by the characterization of its insecticidal effects towards an insect cell line (Sf-9) derived from Spodoptera frugiperda, an insect susceptible to VIP3A(a). VIP3A(a) showed insecticidal activity towards the insect cell line when kept present throughout the experiment. When SF- 9 insect cells are transiently exposed to VIP3A(a) and VIP3A(b), their cell viability was significantly reduced even with exposure times as short as 5 min. Once the incubation time exceeded 10 min, the effects of the VIP3A(a) and VIP3A(b) on insect cell viability over a period of 6 hours were maximal showing a reduction of 90% in cell viability. The cytological changes occurring in SF-9 cells transiently exposed to VIP3A(a) were monitored by microscopy. Small protrusions appeared on the surface of the treated cells some time between 10 and 15 min after their exposure to the VIP3A(a) protein. At this stage, the mitochondria of the cells remained functionally intact as revealed by staining with rhodamine 123, a dye that accumulates in mitochondria with active membrane potential (Johnson, LN. et al. Proc. Νatl. Acad. Sci. USA 77:990-994, 1980). These protrusions eventually disappeared and the cells entered a phase of profuse vacuolization lasting an additional 30 to 60 min. During the final stages, the insect cells are seen to swell before disintegration. For an individual cell, the entire process required 1 to 2 hours. All these cellular events are consistent with previous studies on cells undergoing apoptosis particularly considering that programmed cell death during metamoφhosis of certain insects is accompanied by cellular vacuolization and swelling (Schwartz, L.M. et al. Proc. Natl. Acad. Sci. USA 90:980-984 (1993)).

Recent studies have shown that the distribution of phospholipids in the plasma membrane is affected in very early stages of animal cells undergoing apoptosis (Martin, S. J., et al. J. Exp. Med.:182, 1545-1556, 1995) particularly the externalization of the phosphatidylserine (PS). This process can be visualized by using Annexin V, an anticoagulant protein with high affinity for phosphatidylserine (PS). When VIP3A(a)-treated SF-9 cells were incubated with Annexin V, an externalization of PS was revealed in insect cell membranes as early as 5-10 min after the exposure to VIP3A(a) probably marking the onset of apoptosis .

One of the key molecular events that is the hallmark of apoptosis is endonucleolysis resulting in a double strand DNA break freeing oligonucleosome-sized fragments of 200 base pair and multiples. We examined the occurrence of endonucleolysis in SF-9 cells treated with VIP3A(a) using an in situ detection method and analysing the DNA by agarose gel electrophoresis. Based on the ability of the Klenow enzyme to incoφorated modified nucleotides using the DNA ends generated by DNA fragmentation, SF-9 insect cells showed signs of endonucleolysis as early as 30 min upon their exposure to the VIP3A(a) protein. This stage will coincide with the appearance of membrane-bound subcellular apoptotic bodies visualized in the microscopical observations. These early indications of endonucleolytic activity were confirmed by the detection of DNA fragments in agarose gels characteristic of a chromatin ladder slightly latter in the process. These results corroborated the indications obtained from cytological observations, that the SF-9 cells initiate an apoptotic-type of programmed cell death upon their exposure to the VIP3A(a) protein.

The VIP3A(a) and VIP3A(b) proteins were discovered on the basis of their insecticidal properties against some lepidopteran insects. Therefore, we were interested in knowing whether the VIP3A(a) protein would induce an apoptotic pathway in gut cells of susceptible insects upon its ingestion and thus, it could exert its insecticidal properties by triggering an active process of cell death. Histological and histochemical studies have shown that the VIP3A(a) protein specifically targets the columnar cells of the midgut epithelium of susceptible insects provoking cell changes characterized by membrane protrusions and extensive vacuolization leading to cell death. These cytological changes induced by VIP3A(a) in insect gut cells resemble those described above for SF-9 cells. We then examined whether midgut epithelium cells of susceptible insects undergo endonucleolysis upon ingesting diet containing VIP3A(a) by in situ detection (Cuvillier, O., et al. Nature 381 :800-803 (1996)) of DNA fragmentation. When sections of midgut tissue from black cutworm larvae fed with diet either containing VIP3A(a) or control diet, nuclei staining indicative of DNA fragmentation was only detectable in the columnar cells of the midgut epithelium exposed to the VIP3A(a) protein. This result indicates that the VIP3A(a) protein induces an endonucleolysis process in the midgut epithelium cells concurrently with the cytological changes reported previously. It is our conclusion that the VIP3A(a) protein likely exerts its insecticidal properties by activating an apoptosis-type of programmed cell death of the midgut epithelium cells of susceptible insects.

Example 10: Isolation of the Receptor for VIP3A(a) from black cutworm

Black cutworm is sensitive to VIP3A(a) and therefore this insect was used for the isolation of the VIP3A(a) receptor. Midgut of third instar black cutworm larvae were collected by dissection and immediately frozen in liquid nitrogen. One gram of midgut tissue was used to isolate mRNA by following the protocol described in the two-hybrid cDNA library construction kit provided by Clontech (1997). Ten micrograms of poly A⁺ RNA were used as starting material. In first strand synthesis, both random and lock-docking oligo(dT)₂₅d(A/C/G) primers are used in separate synthesis with MML reverse transcriptase. The second strand cDNA was achieved by an optimal ratio of DNA polymerase to Rnase H activity in the second-strand enzyme cocktail. The newly synthesized double stranded cDNA is then iigated to EcoR\-Not\-Sal\ adaptors. The cDNAs were ligated into pGADIO (Vijaychander, S. et al. CLONTECHniques IX-3:8-10, 1994) which provides the activation domain. The v/p3A(a) gene was engineered into the polylinker site of the plasmid pGBT9 in frame with the GAL4-DNA binding domain (Bartel, P.L. et al. Cellular Interactions in Development: A Practical Approach, pp. 153-179, Oxford University Press, 1993). The recombinant pGBT9- v/p3A(a) was transformed into the yeast strain GGY1 ::171 (Gill, G. and Ptashne, M. Cell51 :121-126, 1987) by electroporation (Estruch, J.J. et al. BioTechniques 16:610-612, 1994). The transformed yeast was selected in minimal media without tryptophan (Bartel, P.L. et al. Cellular Interactions in Development: A Practical Approach, pp. 153-179, Oxford University Press, 1993). The expression of the VIP3A(a) protein in the recombinant yeast was confirmed by westem analysis. The yeast strain GGY1 ::171- VIP3A(a) was transformed with the black cutworm cDNA library represented in pGADI O. GGY1 ::171 possess the HIS3 marker under the control of GAL4 recognition sites. The HIS3 gene allows a positive growth selection for clones that are transformed by two interacting hybrid constructs. After plating more than 200,000 recombinant clones, only one was able to grow in minimal media without histidine. The plasmid DNA of the positive yeast colony was isolated by the yeast lysis buffer method (Kaiser, P. and Auer, B. BioTechniques 14:552 (1993)) and electroporated into E. coli. The insert containing the cDNA was subcloned into the EcoR\ site of the pBluescript (Stratagene) and sequenced by the dideoxy termination method of Sanger et al., Proc. Natl. Acad. Sci. USA, 74: 5463-5467 (1977), using PRISM Ready Reaction Dye Deoxy Terminator Cycle Sequencing Kits and PRISM Sequenase® Terminator Double- Stranded DNA Sequencing Kit and analysed on an ABI 373 automatic sequencer.

An alternative approach to identify clones encoding for protein(s) that interact with Vip3A consisted of plating yeast transformed with the black cutworm cDNA library represented in pGADI O. After transferring said transformed yeast population to nitrocellulose filters, they were screened with a biotin-labelled Vip3A protein followed by an incubation with a solution containing streptavidin coupled to alkaline phosphatase (AP). After extensive washes, the clone or clones expressing a protein with the ability to bind to Vip3A were visualized by using the substrate 5-bromo-4-chloro-3-indolyl phosphate (BCIP) in combination with nitro blue tetrazolium (NBT). AP cataiizes the formation of insoluble precipitates which developed in dark spots on the nitrocellulose filters. The experimental procedures are described in detail by Sambrook, J. et al. in Molecular Cloning: A Laboratory Manual, pp. 12-21-12.24, Cold Spring Harbor Laboratory, 1989. After re-growing the yeast plates ovemight, the developed spots in the filters were matched to yeast colonies in the original plates. These colonies were grown, their plasmids isolated, and their inserts characterized as described above.

Example 11: Insect Cells Transformed with the Gene for the Receptor Exhibit Apoptosis when Exposed to the VIP3A(a) protein

The receptor in black cutworm midgut cells for the VIP3A(a) protein was cloned into the Xho\-BamH\ site of the Smart 2 cosmid vector (Speek, M. et al Gene 64: 173-177

(1988)), and the recombinant construct was used to transform the Schneider 2 (S2)

Dmsophila cell line using the calcium phosphate co-precipitation method (Clem, R.J. and

Miller. L. K. Mol. Cel. Biol.14: 5212-5222 (1994)). Smart 2 carries the selectable marker ret

(tetracycline) for bacterial transformation and the neo (neomycin) for Dmsophila cell transformation. The neo selectable marker is expressed under the control of the Dmsophila hsp70 promoter. The transformed S2 cells were selected in S2 Dmsophila medium supplemented with 10% of Fetal Seroalbumin and with G418 (1mg/ml) at 30°C (see GIBCO catalogue 1997). Several stably transformed S2 cell lines were established after 45 days of selection in the medium described above.

The sensitivity of the S2 transformed cells to the VIP3A(a) was tested by adding VIP3A(a) protein (at a final concentration of 1 ,7 micrograms per ml) to the media containing the transformed S2 cells that have been previously heat shocked at 42° C 30 min. The induction of apoptosis in transformed S2 cells was confirmed by both microscopical observations and by the TACS Kit, and in situ Apoptosis Detection kit (for detailed description, see Trevigen catalogue 1996).

Example 12: Isolating Homoiogues to the Receptor from Other Insects

The cells of the midgut epithelium of black cutworm larvae possess a receptor that is recognized by the VIP3A(a) protein. Receptors from other insects known to be susceptible to VIP3A(a) are isolated by identifying the DNA sequences in Southern analysis. DNA is prepared, enzyme restricted, run in agarose gels and blotted onto nitrocellulose and/or nylon filters. These filters are probed with the cDNA encoding the receptor from black cutworm using low stringency conditions of hybridization and washing. Genes with a similarity to the black cutworm receptor to VIP3A(a) lower than 50% were identified. The Southern analysis can also be probed against partial sequences of the cDNA which encode specific domains such as death domain or EGF-like motifs with the intention of isolating genes that contain similar domains even though they are functionally different to the black cutworm receptor to VIP3A(a).

The isolation of homoiogues to the black cutworm receptor to VIP3A(a) is be accomplished by the two hybrid system described in Fields, S. and Song, O.-K. Nature 340:245-246 (1989). Isolated mRNA is obtained from an organisms of interest, synthesize cDNAs and clone them into pGADIO or equivalent plasmids. The cDNA library is co- transformed with the pGB9-bearing the v/p3A(a) gene (or homoiogues of this gene) and rescued putative receptors in yeast by means of activating a marker based upon protein- protein interaction between the VIP3A(a) protein (or homoiogues) and the putative receptor.

Homoiogues to the black cutworm receptor to VIP3A(a) are isolated by expressing cDNAs libraries isolated from organisms of interests, cloned into appropriate expression vectors and transformed into host cells such as yeast or insect cells which are known not to have the ability to bind and/or be sensitive to VIP3A(a). The transformed cells are screened based on their gained property of binding VIP3A(a) or undergoing apoptotic responses when incubated with VIP3A(a). In this case, the protein VIP3A(a) is used as probe and its binding will be monitored either by antibodies against VIP3A(a) or by labels such as biotin attached to VIP3A(a).

Example 13: Screening for Novel Compounds that Induce Apoptosis in Insect Cells

Model cell lines for different orders of insects (some examples include Sf-9 cells for lepidopteran, Colorado potato beetle for coleopterans, S2 from Dmsophila for dipterans) is used to screen for novel compounds whose mode of action is induction of apoptosis. The cells are grown in multi-well plates which are used for a high-throughput assay screening for thousands of compounds (both of large and small molecular weight). The compound(s) are added as single component or as mixtures. Compound(s) inducing apoptosis are identified as follows: 1) membrane protrusions are visible in the cell membrane, 2) a reorganization of the phosphatidylserine containing membrane lipids is detectable by using specific proteins with high affinity for phosphatidylserine such as Annexin-V linked to a visual marker, 3) cytoplasmic blebbing is visible in the cell cytoplasm, 4) active mitochondria can be visualized by using vital dyes such as rhodamine 123 that accumulate in mitochondria, 5) DNA fragmentation is detected either by DNA analysis in agarose gels, by ELISA detection of nucleosomal release or by in vivo detection of DNA nicking. All these cytological and molecular features are indicative of apoptosis.

The black cutworm receptor to VIP3A(a) is transformed into S2 cell line. Therefore, isogenic S2 lines are available with and without the said receptor. These cell lines are used to screen compounds that provide a differential response due to the presence of the said receptor. Transformed S2 cells undergoing apoptosis upon exposure to certain compounds are identified as indicated above. The differential response of the transformed versus the non-transformed cell is indicative that the action of the compound is mediated by the cloned receptor. Similar approaches are undertaken with insect cells transformed with receptors homologue to the black cutworm receptor to VIP3A(a). All publications and patent applications mentioned in this specification are indicative of the level of skill of those skilled in the art to which this invention pertains. All publications and patent applications are herein incoφorated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incoφorated by reference.

Although the foregoing invention has been described in some detail by way of illustration and example for puφoses of clarity of understanding, it will be obvious that certain changes and modifications may be practiced within the scope of the appended claims.

SEQUENCE LISTING

( 1 ) GENERAL INFORMATION : (1) GENERAL INFORMATION:

(i) APPLICANT:

(A) NAME: NOVARTTS AG

(B) STREET: Scriwarzwaldallee 215

(C) CITY: Basel

(E) COUNTRY: Switzerland

(F) POSTAL CODE (ZIP) : 4058

(G) TELEPHONE: +4161 324 11 11 (H) TELEFAX: + 4161 322 75 32

. . . . ( ii ) TITLE OF INVENTION : A Novel Class of Proteins for the Control of Plant Pests

( iii ) NUMBER OF SEQUENCES : 20 (iv) COMPUTER READABLE FORM:

(A) MEDIUM TYPE: Floppy disk

(B) COMPUTER: IBM PC corrpatible

(C) OPERATING SYSTEM: PC-DOS/MS-DOS

(D) SOFTWARE: Patentln Release #1.0, Version #1.30

(2) INFORMATION FOR SEQ ID NO:l:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2378 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS : single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: 9..2375

(D) OTHER INFORMATION: /note= "Native DNA sequence encoding VIP3A(a) protein from AB88 as contained in pCIB7104"

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:l:

AGATGAAC ATG AAC AAG AAT AAT ACT AAA TTA AGC ACA AGA GCC TTA CCA 50 Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro 1 5 10

AGT TTT ATT GAT TAT TTT AAT GGC ATT TAT GGA TTT GCC ACT GGT ATC 98 Ser Phe lie Asp Tyr Phe Asn Gly lie Tyr Gly Phe Ala Thr Gly lie 15 20 25 30

_AAA GAC ATT ATG AAC ATG ATT TTT AAA ACG GAT ACA GGT GGT GAT CTA 146 Lys Asp lie Met Asn Met lie Phe Lys Thr Asp Thr Gly Gly Asp Leu 35 40 45

ACC CTA GAC GAA ATT TTA AAG AAT CAG CAG TTA CTA AAT GAT ATT TCT 194 Thr Leu Asp Glu lie Leu Lys Asn Gin Gin Leu Leu Asn Asp lie Ser 50 55 60

GGT AAA TTG GAT GGG GTG AAT GGA AGC TTA AAT GAT CTT ATC GCA CAG 242 Gly Lys Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu lie Ala Gin 65 70 75

GGA AAC TTA AAT ACA GAA TTA TCT AAG GAA ATA TTA AAA ATT GCA AAT 290 Gly Asn Leu Asn Thr Glu Leu Ser Lys Glu lie Leu Lys lie Ala Asn 80 85 90

GAA CAA AAT CAA GTT TTA AAT GAT GTT AAT AAC AAA CTC GAT GCG ATA 338 Glu Gin Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala lie 95 100 105 110

AAT ACG ATG CTT CGG GTA TAT CTA CCT AAA ATT ACC TCT ATG TTG AGT 386 Asn Thr Met Leu Arg Val Tyr Leu Pro Lys lie Thr Ser Met Leu Ser 115 120 125

GAT GTA ATG AAA CAA AAT TAT GCG CTA AGT CTG CAA ATA GAA TAC TTA 434 Asp Val Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin lie Glu Tyr Leu 130 135 140

AGT AAA CAA TTG CAA GAG ATT TCT GAT AAG TTG GAT ATT ATT AAT GTA 482 Ser Lys Gin Leu Gin Glu lie Ser Asp Lys Leu Asp lie lie Asn Val 145 150 155

AAT GTA CTT ATT AAC TCT ACA CTT ACT GAA ATT ACA CCT GCG TAT CAA 530 Asn Val Leu lie Asn Ser Thr Leu Thr Glu lie Thr Pro Ala Tyr Gin 160 165 170

AGG ATT AAA TAT GTG AAC GAA AAA TTT GAG GAA TTA ACT TTT GCT ACA 578 Arg lie Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr 175 180 185 190

GAA ACT AGT TCA AAA GTA AAA AAG GAT GGC TCT CCT GCA GAT ATT CTT 626 Glu Thr Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp lie Leu 195 200 205

GAT GAG TTA ACT GAG TTA ACT GAA CTA GCG AAA AGT GTA ACA AAA AAT 674 Asp Glu Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn 210 215 220

GAT GTG GAT GGT TTT GAA TTT TAC CTT AAT ACA TTC CAC GAT GTA ATG 722 Asp Val Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met 225 230 235

GTA GGA AAT AAT TTA TTC GGG CGT TCA GCT TTA AAA ACT GCA TCG GAA 770 Val Gly Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu 240 245 250

TTA ATT ACT AAA GAA AAT GTG AAA ACA AGT GGC AGT GAG GTC GGA AAT 818 Leu lie Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn 255 260 265 270 GTT TAT AAC TTC TTA ATT GTA TTA ACA GCT CTG CAA GCC CAA GCT TTT 866

Val Tyr Asn Phe Leu lie Val Leu Thr Ala Leu Gin Ala Gin Ala Phe

275 280 285

CTT ACT TTA ACA ACA TGC CGA AAA TTA TTA GGC TTA GCA GAT ATT GAT 914

Leu Thr Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp lie Asp 290 295 300

TAT ACT TCT ATT ATG AAT GAA CAT TTA AAT AAG GAA AAA GAG GAA TTT 962

Tyr Thr Ser lie Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe 305 310 315

AGA GTA AAC ATC CTC CCT ACA CTT TCT AAT ACT TTT TCT AAT CCT AAT 1010

Arg Val Asn lie Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn 320 325 330

TAT GCA AAA GTT AAA GGA AGT GAT GAA GAT GCA AAG ATG ATT GTG GAA 1058

Tyr Ala Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met lie Val Glu

335 340 345 350

GCT AAA CCA GGA CAT GCA TTG ATT GGG TTT GAA ATT AGT AAT GAT TCA 1106

Ala Lys Pro Gly His Ala Leu lie Gly Phe Glu lie Ser Asn Asp Ser

355 360 365

ATT ACA GTA TTA AAA GTA TAT GAG GCT AAG CTA AAA CAA AAT TAT CAA 1154 lie Thr Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin 370 375 380

GTC GAT AAG GAT TCC TTA TCG GAA GTT ATT TAT GGT GAT ATG GAT AAA 1202

Val Asp Lys Asp Ser Leu Ser Glu Val lie Tyr Gly Asp Met Asp Lys 385 390 395

TTA TTG TGC CCA GAT CAA TCT GAA CAA ATC TAT TAT ACA AAT AAC ATA 1250

Leu Leu Cys Pro Asp Gin Ser Glu Gin lie Tyr Tyr Thr Asn Asn lie 400 405 410

GTA TTT CCA AAT GAA TAT GTA ATT ACT AAA ATT GAT TTC ACT AAA AAA 1298

Val Phe Pro Asn Glu Tyr Val lie Thr Lys lie Asp Phe Thr Lys Lys

415 420 425 430

ATG AAA ACT TTA AGA TAT GAG GTA ACA GCG AAT TTT TAT GAT TCT TCT 1346

Met Lys Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser

435 440 445

ACA GGA GAA ATT GAC TTA AAT AAG AAA AAA GTA GAA TCA AGT GAA GCG 1394

Thr Gly Glu lie Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala 450 455 460

GAG TAT AGA ACG TTA AGT GCT AAT GAT GAT GGG GTG TAT ATG CCG TTA 1442

Glu Tyr Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu 465 470 475

GGT GTC ATC AGT GAA ACA TTT TTG ACT CCG ATT AAT GGG TTT GGC CTC 1490

Gly Val lie Ser Glu Thr Phe Leu Thr Pro lie Asn Gly Phe Gly Leu 480 485 490

CAA GCT GAT GAA AAT TCA AGA TTA ATT ACT TTA ACA TGT AAA TCA TAT 1538

Gin Ala Asp Glu Asn Ser Arg Leu lie Thr Leu Thr Cys Lys Ser Tyr

495 500 505 510

TTA AGA GAA CTA CTG CTA GCA ACA GAC TTA AGC AAT AAA GAA ACT AAA 1586 Leu Arg Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys

515 520 525 TTG ATC GTC CCG CCA AGT GGT TTT ATT AGC AAT ATT GTA GAG AAC GGG 1634

Leu lie Val Pro Pro Ser Gly Phe lie Ser Asn lie Val Glu Asn Gly

530 535 540

TCC ATA GAA GAG GAC AAT TTA GAG CCG TGG AAA GCA AAT AAT AAG AAT 1682

Ser lie Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn 545 550 555

GCG TAT GTA GAT CAT ACA GGC GGA GTG AAT GGA ACT AAA GCT TTA TAT 1730

Ala Tyr Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr 560 565 570

GTT CAT AAG GAC GGA GGA ATT TCA CAA TTT ATT GGA GAT AAG TTA AAA 1778

Val His Lys Asp Gly Gly lie Ser Gin Phe lie Gly Asp Lys Leu Lys

575 580 585 590

CCG AAA ACT GAG TAT GTA ATC CAA TAT ACT GTT AAA GGA AAA CCT TCT 1826

Pro Lys Thr Glu Tyr Val lie Gin Tyr Thr Val Lys Gly Lys Pro Ser 595 600 605

ATT CAT TTA AAA GAT GAA AAT ACT GGA TAT ATT CAT TAT GAA GAT ACA 1874 lie His Leu Lys Asp Glu Asn Thr Gly Tyr lie His Tyr Glu Asp Thr

610 615 620

AAT AAT AAT TTA GAA GAT TAT CAA ACT ATT AAT AAA CGT TTT ACT ACA 1922

Asn Asn Asn Leu Glu Asp Tyr Gin Thr lie Asn Lys Arg Phe Thr Thr 625 630 635

GGA ACT GAT TTA AAG GGA GTG TAT TTA ATT TTA AAA AGT CAA AAT GGA 1970

Gly Thr Asp Leu Lys Gly Val Tyr Leu lie Leu Lys Ser Gin Asn Gly 640 645 650

GAT GAA GCT TGG GGA GAT AAC TTT ATT ATT TTG GAA ATT AGT CCT TCT 2018

Asp Glu Ala Trp Gly Asp Asn Phe lie lie Leu Glu lie Ser Pro Ser

655 660 665 670

GAA AAG TTA TTA AGT CCA GAA TTA ATT AAT ACA AAT AAT TGG ACG AGT 2066

Glu Lys Leu Leu Ser Pro Glu Leu lie Asn Thr Asn Asn Trp Thr Ser 675 680 685

ACG GGA TCA ACT AAT ATT AGC GGT AAT ACA CTC ACT CTT TAT CAG GGA 2114

Thr Gly Ser Thr Asn lie Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly

690 695 700

GGA CGA GGG ATT CTA AAA CAA AAC CTT CAA TTA GAT AGT TTT TCA ACT 2162

Gly Arg Gly lie Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr 705 710 715

TAT AGA GTG TAT TTT TCT GTG TCC GGA GAT GCT AAT GTA AGG ATT AGA 2210

Tyr Arg Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg lie Arg 720 725 730

AAT TCT AGG GAA GTG TTA TTT GAA AAA AGA TAT ATG AGC GGT GCT AAA 2258

Asn Ser Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys

735 740 745 750

GAT GTT TCT GAA ATG TTC ACT ACA AAA TTT GAG AAA GAT AAC TTT TAT 2306

Asp Val Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr 755 760 765

ATA GAG CTT TCT CAA GGG AAT AAT TTA TAT GGT GGT CCT ATT GTA CAT 2354 lie Glu Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro lie Val His

770 775 780

TTT TAC GAT GTC TCT ATT AAG TAA 2378 Phe Tyr Asp Val Ser lie Lys 785

(2) INFORMATION FOR SEQ ID NO: 2:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 789 amino acids

(B) TYPE: amino acid (D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:

Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 lie Asp Tyr Phe Asn Gly lie Tyr Gly Phe Ala Thr Gly lie Lys Asp 20 25 30 lie Met Asn Met lie Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 35 40 45

Asp Glu lie Leu Lys Asn Gin Gin Leu Leu Asn Asp lie Ser Gly Lys 50 55 60

Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu lie Ala Gin Gly Asn 65 70 75 80

Leu Asn Thr Glu Leu Ser Lys Glu lie Leu Lys lie Ala Asn Glu Gin 85 90 95

Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala lie Asn Thr 100 105 110

Met Leu Arg Val Tyr Leu Pro Lys lie Thr Ser Met Leu Ser Asp Val 115 120 125

Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin lie Glu Tyr Leu Ser Lys 130 135 140

Gin Leu Gin Glu lie Ser Asp Lys Leu Asp lie lie Asn Val Asn Val 145 150 155 160

Leu lie Asn Ser Thr Leu Thr Glu lie Thr Pro Ala Tyr Gin Arg lie 165 170 175

Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190

Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp lie Leu Asp Glu 195 200 205

Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220

Asp Gly Phe Glu Phe Tyr Leu ASP Thr Phe His Asp Val Met Val Gly 225 230 235 240

Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu lie 245 250 255

Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270 Asn Phe Leu lie Val Leu Thr Ala Leu Gin Ala Gin Ala Phe Leu Thr 275 280 285

Leu Thr Thr Cys Arg Lys Leu Leu Gly Leu Ala Asp lie Asp Tyr Thr 290 295 300

Ser lie Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320

Asn lie Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335

Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met lie Val Glu Ala Lys 340 345 350

Pro Gly His Ala Leu lie Gly Phe Glu lie Ser Asn Asp Ser lie Thr 355 360 365

Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380

Lys Asp Ser Leu Ser Glu Val lie Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400

Cys Pro Asp Gin Ser Glu Gin lie Tyr Tyr Thr Asn Asn lie Val Phe 405 410 415

Pro Asn Glu Tyr Val lie Thr Lys lie Asp Phe Thr Lys Lys Met Lys 420 425 430

Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445

Glu lie Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460

Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 lie Ser Glu Thr Phe Leu Thr Pro lie Asn Gly Phe Gly Leu Gin Ala 485 490 495

Asp Glu Asn Ser Arg Leu lie Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510

Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu lie 515 520 525

Val Pro Pro Ser Gly Phe lie Ser Asn lie Val Glu Asn Gly Ser lie 530 535 540

Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560

Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tvr Val His 565 570 575

Lys Asp Gly Gly lie Ser Gin Phe lie Gly Asp Lys Leu Lys Pro Lys 580 585 590

Thr Glu Tyr Val lie Gin Tyr Thr Val Lys Gly Lys Pro Ser lie His 595 600 605

Leu Lys Asp Glu Asn Thr Gly Tyr lie His Tyr Glu Asp Thr Asn Asn 610 615 620

Asn Leu Glu Asp Tyr Gin Thr lie Asn Lys Arg Phe Thr Thr Gly Thr 625 630 635 640

Asp Leu Lys Gly Val Tyr Leu lie Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655

Ala Trp Gly Asp Asn Phe lie lie Leu Glu lie Ser Pro Ser Glu Lys 660 665 670

Leu Leu Ser Pro Glu Leu lie Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685

Ser Thr Asn lie Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700

Gly lie Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720

Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg lie Arg Asn Ser 725 730 735

Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750

Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr lie Glu 755 760 765

Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro lie Val His Phe Tyr 770 775 780

Asp Val Ser lie Lys 785

(2) INFORMATION FOR SEQ ID NO: 3:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2612 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: 118..2484

(D) OTHER INFORMATION: /note= "Native DNA sequence encoding VIP3A(b) from AB424"

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:3:

ATTGAAATTG ATAAAAAGTT ATGAGTGTTT AATAATCAGT AATTACCAAT AAAGAATTAA 60

GAATACAAGT TTACAAGAAA TAAGTGTTAC AAAAAATAGC TGAAAAGGAA GATGAAC 117

ATG AAC AAG AAT AAT ACT AAA TTA AGC ACA AGA GCC TTA CCA AGT TTT 165 Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 790 795 800 805 ATT GAT TAT TTC AAT GGC ATT TAT GGA TTT GCC ACT GGT ATC AAA GAC 213 lie Asp Tyr Phe Asn Gly lie Tyr Gly Phe Ala Thr Gly lie Lys Asp 810 815 820

ATT ATG AAC ATG ATT TTT AAA ACG GAT ACA GGT GGT GAT CTA ACC CTA 261 lie Met Asn Met lie Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 825 830 835

GAC GAA ATT TTA AAG AAT CAG CAG CTA CTA AAT GAT ATT TCT GGT AAA 309 Asp Glu lie Leu Lys Asn Gin Gin Leu Leu Asn Asp lie Ser Gly Lys 840 845 850

TTG GAT GGG GTG AAT GGA AGC TTA AAT GAT CTT ATC GCA CAG GGA AAC 357 Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu lie Ala Gin Gly Asn 855 860 865

TTA AAT ACA GAA TTA TCT AAG GAA ATA TTA AAA ATT GCA AAT GAA CAA 405 Leu Asn Thr Glu Leu Ser Lys Glu lie Leu Lys lie Ala Asn Glu Gin 870 875 880 885

AAT CAA GTT TTA AAT GAT GTT AAT AAC AAA CTC GAT GCG ATA AAT ACG 453 Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala lie Asn Thr 890 895 900

ATG CTT CGG GTA TAT CTA CCT AAA ATT ACC TCT ATG TTG AGT GAT GTA 501 Met Leu Arg Val Tyr Leu Pro Lys lie Thr Ser Met Leu Ser Asp Val 905 910 915

ATG AAA CAA AAT TAT GCG CTA AGT CTG CAA ATA GAA TAC TTA AGT AAA 549 Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin lie Glu Tyr Leu Ser Lys 920 925 930

CAA TTG CAA GAG ATT TCT GAT AAG TTG GAT ATT ATT AAT GTA AAT GTA 597 Gin Leu Gin Glu lie Ser Asp Lys Leu Asp lie lie Asn Val Asn Val 935 940 945

CTT ATT AAC TCT ACA CTT ACT GAA ATT ACA CCT GCG TAT CAA AGG ATT 645 Leu lie Asn Ser Thr Leu Thr Glu lie Thr Pro Ala Tyr Gin Arg lie 950 955 960 965

AAA TAT GTG AAC GAA AAA TTT GAG GAA TTA ACT TTT GCT ACA GAA ACT 693 Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 970 975 980

AGT TCA AAA GTA AAA AAG GAT GGC TCT CCT GCA GAT ATT CGT GAT GAG 741 Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp lie Arg Asp Glu 985 990 995

TTA ACT GAG TTA ACT GAA CTA GCG AAA AGT GTA ACA AAA AAT GAT GTG 789 Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 1000 1005 1010

GAT GGT TTT GAA TTT TAC CTT AAT ACA TTC CAC GAT GTA ATG GTA GGA 837 Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 1015 1020 1025

AAT AAT TTA TTC GGG CGT TCA GCT TTA AAA ACT GCA TCG GAA TTA ATT 8-85 Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu lie 1030 1035 1040 1045

ACT AAA GAA AAT GTG AAA ACA AGT GGC AGT GAG GTC GGA AAT GTT TAT 933 Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 1050 1055 1060 AAC TTC CTA ATT GTA TTA ACA GCT CTG CAA GCA AAA GCT TTT CTT ACT 981 Asn Phe Leu lie Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 1065 1070 1075

TTA ACA CCA TGC CGA AAA TTA TTA GGC TTA GCA GAT ATT GAT TAT ACT 102 Leu Thr Pro Cys Arg Lys Leu Leu Gly Leu Ala Asp lie Asp Tyr Thr 1080 1085 1090

TCT ATT ATG AAT GAA CAT TTA AAT AAG GAA AAA GAG GAA TTT AGA GTA 1077 Ser lie Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 1095 1100 1105

AAC ATC CTC CCT ACA CTT TCT AAT ACT TTT TCT AAT CCT AAT TAT GCA 1125 Asn lie Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 1110 1115 1120 1125

AAA GTT AAA GGA AGT GAT GAA GAT GCA AAG ATG ATT GTG GAA GCT AAA 1173 Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met lie Val Glu Ala Lys 1130 1135 1140

CCA GGA CAT GCA TTG ATT GGG TTT GAA ATT AGT AAT GAT TCA ATT ACA 1221 Pro Gly His Ala Leu lie Gly Phe Glu lie Ser Asn Asp Ser lie Thr 1145 1150 1155

GTA TTA AAA GTA TAT GAG GCT AAG CTA AAA CAA AAT TAT CAA GTC GAT 1269 Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 1160 1165 1170

AAG GAT TCC TTA TCG GAA GTT ATT TAT GGC GAT ATG GAT AAA TTA TTG 1317 Lys Asp Ser Leu Ser Glu Val lie Tyr Gly Asp Met Asp Lys Leu Leu 1175 1180 1185

TGC CCA GAT CAA TCT GGA CAA ATC TAT TAT ACA AAT AAC ATA GTA TTT 1365 Cys Pro Asp Gin Ser Gly Gin lie Tyr Tyr Thr Asn Asn lie Val Phe 1190 1195 1200 1205

CCA AAT GAA TAT GTA ATT ACT AAA ATT GAT TTC ACT AAA AAA ATG AAA 1413 Pro Asn Glu Tyr Val lie Thr Lys lie Asp Phe Thr Lys Lys Met Lys 1210 1215 1220

ACT TTA AGA TAT GAG GTA ACA GCG AAT TTT TAT GAT TCT TCT ACA GGA 1461 Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 1225 1230 1235

GAA ATT GAC TTA AAT AAG AAA AAA GTA GAA TCA AGT GAA GCG GAG TAT 1509 Glu lie Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 1240 1245 1250

AGA ACG TTA AGT GCT AAT GAT GAT GGG GTG TAT ATG CCG TTA GGT GTC 1557 Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 1255 1260 1265

ATC AGT GAA ACA TTT TTG ACT CCG ATT AAT GGG TTT GGC CTC CAA GCT 1605 lie Ser Glu Thr Phe Leu Thr Pro lie Asn Gly Phe Gly Leu Gin Ala 1270 1275 1280 1285

GAT GAA AAT TCA AGA TTA ATT ACT TTA ACA TGT AAA TCA TAT TTA AGA 1653 Asp Glu Asn Ser Arg Leu lie Thr Leu Thr Cys Lys Ser Tyr Leu Arg 1290 1295 1300

GAA CTA CTG CTA GCA ACA GAC TTA AGC AAT AAA GAA ACT AAA TTG ATC 1701 Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu lie 1305 1310 1315

GTC CCG CCA AGT GGT TTT ATT AGC AAT ATT GTA GAG AAC GGG TCC ATA 1749 Val Pro Pro Ser Gly Phe lie Ser Asn lie Val Glu Asn Gly Ser lie 1320 1325 1330

GAA GAG GAC AAT TTA GAG CCG TGG AAA GCA AAT AAT AAG AAT GCG TAT 1797 Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 1335 1340 1345

GTA GAT CAT ACA GGC GGA GTG AAT GGA ACT AAA GCT TTA TAT GTT CAT 1845 Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 1350 1355 1360 1365

AAG GAC GGA GGA ATT TCA CAA TTT ATT GGA GAT AAG TTA AAA CCG AAA 1893 Lys Asp Gly Gly lie Ser Gin Phe lie Gly Asp Lys Leu Lys Pro Lys 1370 1375 1380

ACT GAG TAT GTA ATC CAA TAT ACT GTT AAA GGA AAA CCT TCT ATT CAT 1941 Thr Glu Tyr Val lie Gin Tyr Thr Val Lys Gly Lys Pro Ser lie His 1385 1390 1395

TTA AAA GAT GAA AAT ACT GGA TAT ATT CAT TAT GAA GAT ACA AAT AAT 1989 Leu Lys Asp Glu Asn Thr Gly Tyr lie His Tyr Glu Asp Thr Asn Asn 1400 1405 1410

AAT TTA GAA GAT TAT CAA ACT ATT AAT AAA CGT TTT ACT ACA GGA ACT 2037 Asn Leu Glu Asp Tyr Gin Thr lie Asn Lys Arg Phe Thr Thr Gly Thr 1415 1420 1425

GAT TTA AAG GGA GTG TAT TTA ATT TTA AAA AGT CAA AAT GGA GAT GAA 2085 Asp Leu Lys Gly Val Tyr Leu lie Leu Lys Ser Gin Asn Gly Asp Glu 1430 1435 1440 1445

GCT TGG GGA GAT AAC TTT ATT ATT TTG GAA ATT AGT CCT TCT GAA AAG 2133 Ala Trp Gly Asp Asn Phe lie lie Leu Glu lie Ser Pro Ser Glu Lys 1450 1455 1460

TTA TTA AGT CCA GAA TTA ATT AAT ACA AAT AAT TGG ACG AGT ACG GGA 2181 Leu Leu Ser Pro Glu Leu lie Asn Thr Asn Asn Trp Thr Ser Thr Gly 1465 1470 1475

TCA ACT AAT ATT AGC GGT AAT ACA CTC ACT CTT TAT CAG GGA GGA CGA 2229 Ser Thr Asn lie Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 1480 1485 1490

GGG ATT CTA AAA CAA AAC CTT CAA TTA GAT AGT TTT TCA ACT TAT AGA 2277 Gly lie Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 1495 1500 1505

GTG TAT TTC TCT GTG TCC GGA GAT GCT AAT GTA AGG ATT AGA AAT TCT 2325 Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg lie Arg Asn Ser 1510 1515 1520 1525

AGG GAA GTG TTA TTT GAA AAA AGA TAT ATG AGC GGT GCT AAA GAT GTT 2373 Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 1530 1535 1540

TCT GAA ATG TTC ACT ACA AAA TTT GAG AAA GAT AAC TTC TAT ATA GAG 2421 Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr lie Glu 1545 1550 1555

CTT TCT CAA GGG AAT AAT TTA TAT GGT GGT CCT ATT GTA CAT TTT TAC 2469 Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro lie Val His Phe Tyr 1560 1565 1570

GAT GTC TCT ATT AAG TAAGATCGGG ATCTAATATT AACAGTTTTT AGAAGCTAAT 2524 Asp Val Ser lie Lys 1575 TCTTGTATAA TGTCCTTGAT TATGGAAAAA CACAATTTTG TTTGCTAAGA TGTATATATA 2584 GCTCACTCAT TAAAAGGCAA TCAAGCTT 2612

(2) INFORMATION FOR SEQ ID NO: 4:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 789 amino acids

(B) TYPE: amino acid (D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 4:

Met Asn Lys Asn Asn Thr Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 lie Asp Tyr Phe Asn Gly lie Tyr Gly Phe Ala Thr Gly lie Lys Asp 20 25 30 lie Met Asn Met lie Phe Lys Thr Asp Thr Gly Gly Asp Leu Thr Leu 35 40 45

Asp Glu lie Leu Lys Asn Gin Gin Leu Leu Asn Asp lie Ser Gly Lys 50 55 60

Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu lie Ala Gin Gly Asn 65 70 75 80

Leu Asn Thr Glu Leu Ser Lys Glu lie Leu Lys lie Ala Asn Glu Gin 85 90 95

Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala lie Asn Thr 100 105 110

Met Leu Arg Val Tyr Leu Pro Lys lie Thr Ser Met Leu Ser Asp Val 115 120 125

Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin lie Glu Tyr Leu Ser Lys 130 135 140

Gin Leu Gin Glu lie Ser Asp Lys Leu Asp lie lie Asn Val Asn Val 145 150 155 160

Leu lie Asn Ser Thr Leu Thr Glu lie Thr Pro Ala Tyr Gin Arg lie 165 170 175

Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190

Ser Ser Lys Val Lys Lys Asp Glv Ser Pro Ala Asp lie Arg Asp Glu 195 200 205

Leu Thr Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Lys Asn Asp Val 210 215 220

Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240

Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu lie 245 250 255 Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270

Asn Phe Leu lie Val Leu Thr Ala Leu Gin Ala Lys Ala Phe Leu Thr 275 280 285

Leu Thr Pro Cys Arg Lys Leu Leu Gly Leu Ala Asp lie Asp Tyr Thr 290 295 300

Ser lie Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320

Asn lie Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335

Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met lie Val Glu Ala Lys 340 345 350

Pro Gly His Ala Leu lie Gly Phe Glu lie Ser Asn Asp Ser lie Thr 355 360 365

Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380

Lys Asp Ser Leu Ser Glu Val lie Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400

Cys Pro Asp Gin Ser Gly Gin lie Tyr Tyr Thr Asn Asn lie Val Phe 405 410 415

Pro Asn Glu Tyr Val lie Thr Lys lie Asp Phe Thr Lys Lys Met Lys 420 425 430

Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445

Glu lie Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460

Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 lie Ser Glu Thr Phe Leu Thr Pro lie Asn Gly Phe Gly Leu Gin Ala 485 490 495

Asp Glu Asn Ser Arg Leu lie Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510

Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu lie 515 520 525

Val Pro Pro Ser Gly Phe lie Ser Asn lie Val Glu Asn Gly Ser lie 530 535 540

Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560

Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575

Lys Asp Gly Gly lie Ser Gin Phe lie Gly Asp Lys Leu Lys Pro Lys 580 585 590

Thr Glu Tyr Val lie Gin Tyr Thr Val Lys Gly Lys Pro Ser lie His 595 600 605

Leu Lys Asp Glu Asn Thr Gly Tyr lie His Tyr Glu Asp Thr Asn Asn 610 615 620

Asn Leu Glu Asp Tyr Gin Thr lie Asn Lys Arg Phe Thr Thr Gly Thr 625 630 635 640

Asp Leu Lys Gly Val Tyr Leu lie Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655

Ala Trp Gly Asp Asn Phe lie lie Leu Glu lie Ser Pro Ser Glu Lys 660 665 670

Leu Leu Ser Pro Glu Leu lie Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685

Ser Thr Asn lie Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700

Gly lie Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720

Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg lie Arg Asn Ser 725 730 735

Arg Glu Val Leu Phe Glu Lys Arg Tyr Met Ser Gly Ala Lys Asp Val 740 745 750

Ser Glu Met Phe Thr Thr Lys Phe Glu Lys Asp Asn Phe Tyr lie Glu 755 760 765

Leu Ser Gin Gly Asn Asn Leu Tyr Gly Gly Pro lie Val His Phe Tyr 770 775 780

Asp Val Ser lie Lys 785

(2) INFORMATION FOR SEQ ID NO : 5 :

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2364 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS : single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: DNA (genomic) (iii) HYPOTHETICAL: NO

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: 56.-2295

(D) OTHER INFORMATION: product= "VIP3A(c) protein"

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 5:

AATACAATTT ACGAGGGATA AGTGTTACAA AGAATAGCTG AGGAGGGAGA TGAAC ATG 58

Met 1 AAC AAG AAT AAT GCT AAA TTA AGC ACA AGA GCC TTA CCA AGT TTT ATT 106 Asn Lys Asn Asn Ala Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe lie 5 10 15

GAT TAT TTC AAT GGC ATT TAT GGA TTT GCC ACT GGT ATC AAA GAC ATT 154 Asp Tyr Phe Asn Gly lie Tyr Gly Phe Ala Thr Gly ie Lys Asp lie 20 25 30

ATG AAC ATG ATT TTT AAA ACG GAT ACA GGT GGT GAT CTA GCC CTA GAC 202 Met Asn Met lie Phe Lys Thr Asp Thr Gly Gly Asp Leu Ala Leu Asp 35 40 45

GAA ATT TTA GAG AAT CAG CAG CTA CTA AAT GAT ATT TCT GGT AAA TTG 250 Glu lie Leu Glu Asn Gin Gin Leu Leu Asn Asp lie Ser Gly Lys Leu 50 55 60 65

GAT GGG GTG AAT GGA AGC TTA AAT GAT CTT ATC GCA CAG GGA AAC TTA 298 Asp Gly Val Asn Gly Ser Leu Asn Asp Leu lie Ala Gin Gly Asn Leu 70 75 80

AAT ACA GAA TTA TCT AAG GAA ATA TTA AAA ATT GCA AAT GAA CAA AAT 346 Asn Thr Glu Leu Ser Lys Glu lie Leu Lys lie Ala Asn Glu Gin Asn 85 90 95

CAA GTT TTA AAT GAT GTT AAT AAC AAA CTC GAT GCG ATA AAT ACG ATG 394 Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala lie Asn Thr Met 100 105 110

CTT CGG GTA TAT CTA CCT AAA ATT ACC TCT ATG TTG AGT GAT GTA ATG 442 Leu Arg Val Tyr Leu Pro Lys lie Thr Ser Met Leu Ser Asp Val Met 115 120 125

AAA CAA AAT TAT GCG CTA AGT CTG CAA ATA GAA TAC TTA AGT AAA CAA 490 Lys Gin Asn Tyr Ala Leu Ser Leu Gin lie Glu Tyr Leu Ser Lys Gin 130 135 140 145

TTG CAA GAG ATT TCT GAT AAG TTG GAT ATT ATT AAT GTA AAT GTA CTT 538 Leu Gin Glu lie Ser Asp Lys Leu Asp lie lie Asn Val Asn Val Leu 150 155 160

ATT AAC TCT ACA CTT ACT GAA ATT ACA CCT GCG TAT CAA AGG ATT AAA 586 lie Asn Ser Thr Leu Thr Glu lie Thr Pro Ala Tyr Gin Arg lie Lys 165 170 175

TAT GTG AAC GAA AAA TTT GAG GAA TTA ACT TTT GCT ACA GAA ACT AGT 634 Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr Ser 180 185 190

TCA AAA GTA AAA AAG GAT GGC TCT CCT GCA GAT ATT CGT GAT GAG TTA 682 Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp lie Arg Asp Glu Leu 195 200 205

AGT GAG TTA ACT GAA CTA GCG AAA AGT GTA ACA CAA AAT GAT GTG GAT 730 Ser Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Gin Asn Asp Val Asp 210 215 220 225

GGT TTT GAA TTT TAC CTT AAT ACA TTC CAC GAT GTA ATG GTA GGA AAT 778 Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly Asn 230 235 240 AAT TTA TTC GGG CGT TCA GCT TTA AAA ACT GCA TCG GAA TTA ATT ACT 826 Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu lie Thr 245 250 255

AAA GAA AAT GTG AAA ACA AGT GGC AGT GAG GTC GGA AAT GTT TAT AAC 874 Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr Asn 260 265 270

TTC CTA ATT GTA TTA ACA GCT CTG CAA GCA CAA GCT TTT CTT ACT TTA 922 Phe Leu lie Val Leu Thr Ala Leu Gin Ala Gin Ala Phe Leu Thr Leu 275 280 285

ACA CCA TGC CGA AAA TTA TTA GGC TTA GCA GAT ATT GAT TAT ACT TCT 970 Thr Pro Cys Arg Lys Leu Leu Gly Leu Ala Asp lie Asp Tyr Thr Ser 290 295 300 305

ATT ATG AAT GAA CAT TTA AAT AAG GAA AAA GAG GAA TTT AGA GTA AAC 1018 lie Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val Asn 310 315 320

ATC CTC CCT ACA CTT TCT AAT ACT TTT TCT AAT CCT AAT TAT GCA AAA 1066 lie Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala Lys 325 330 335

GTT AAA GGA AGT GAT GAA GAT GCA AAG ATG ATT GTG GAA GCT AAA CCA 1114 Val Lys Gly Ser Asp Glu Asp Ala Lys Met lie Val Glu Ala Lys Pro 340 345 350

GGA CAT GCA TTG ATT GGG TTT GAA ATT AGT AAT GAT TCA ATT ACA GTA 1162 Gly His Ala Leu lie Gly Phe Glu lie Ser Asn Asp Ser lie Thr Val 355 360 365

TTA AAA GTA TAT GAG GCT AAG CTA AAA CAA AAT TAT CAA GTC GAT AAG 1210 Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp Lys 370 375 380 385

GAT TCC TTA TCG GAA GTT ATT TAT GGC GAT ATG GAT AAA TTA TTG TGC 1258 Asp Ser Leu Ser Glu Val lie Tyr Gly Asp Met Asp Lys Leu Leu Cys 390 395 400

CCA GAT CAA TCT GGA CAA ATC TAT TAT ACA AAT AAC ATA GTA TTT CCA 1306 Pro Asp Gin Ser Gly Gin lie Tyr Tyr Thr Asn Asn lie Val Phe Pro 405 410 415

AAT GAA TAT GTA ATT ACT AAA ATT GAT TTC ACT AAA AAA ATG AAA ACT 1354 Asn Glu Tyr Val lie Thr Lys lie Asp Phe Thr Lys Lys Met Lys Thr 420 425 430

TTA AGA TAT GAG GTA ACA GCG AAT TTT TAT GAT TCT TCT ACA GGA GAA 1402 Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly Glu 435 440 445

ATT GAC TTA AAT AAG AAA AAA GTA GAA TCA AGT GAA GCG GAG TAT AGA 1450- lie Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr Arg 450 455 460 465

ACG TTA AGT GCT AAT GAT GAT GGG GTG TAT ATG CCG TTA GGT GTC ATC 1498 Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val lie 470 475 480 AGT GAA ACA TTT TTG ACT CCG ATT AAT GGG TTT GGC CTC CAA GCT GAT 1546 Ser Glu Thr Phe Leu Thr Pro lie Asn Gly Phe Gly Leu Gin Ala Asp 485 490 495

GAA AAT TCA AGA TTA ATT ACT TTA ACA TGT AAA TCA TAT TTA AGA GAA 1594 Glu Asn Ser Arg Leu lie Thr Leu Thr Cys Lys Ser Tyr Leu Arg Glu 500 505 510

CTA CTG CTA GCA ACA GAC TTA AGC AAT AAA GAA ACT AAA TTG ATC GTC 1642 Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu lie Val 515 520 525

CCG CCA AGT GGT TTT ATT AGC AAT ATT GTA GAG AAC GGG TCC ATA GAA 1690 Pro Pro Ser Gly Phe lie Ser Asn lie Val Glu Asn Gly Ser lie Glu 530 535 540 545

GAG GAC AAT TTA GAG CCG TGG AAA GCA AAT AAT AAG AAT GCG TAT GTA 1738 Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr Val 550 555 560

GAT CAT ACA GGC GGA GTG AAT GGA ACT AAA GCT TTA TAT GTT CAT AAG 1786 Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His Lys 565 570 575

GAC GGA GGA ATT TCA CAA TTT ATT GGA GAT AAG TTA AAA CCG AAA ACT 1834 Asp Gly Gly lie Ser Gin Phe lie Gly Asp Lys Leu Lys Pro Lys Thr 580 585 590

GAG TAT GTA ATC CAA TAT ACT GTT AAA GGA AAA CCT TCT ATT CAT TTA 1882 Glu Tyr Val lie Gin Tyr Thr Val Lys Gly Lys Pro Ser lie His Leu 595 600 605

AAA GAT GAA AAT ACT GGA TAT ATT CAT TAT GAA GAT ACA AAT AAT AAT 1930 Lys Asp Glu Asn Thr Gly Tyr lie His Tyr Glu Asp Thr Asn Asn Asn 610 615 620 625

TTA GAA GAT TAT CAA ACT ATT AAT AAA CGT TTT ACT ACA GGA ACT GAT 1978 Leu Glu Asp Tyr Gin Thr lie Asn Lys Arg Phe Thr Thr Gly Thr Asp 630 635 640

TTA AAG GGA GTG TAT TTA ATT TTA AAA AGT CAA AAT GGA GAT GAA GCT 2026 Leu Lys Gly Val Tyr Leu lie Leu Lys Ser Gin Asn Gly Asp Glu Ala 645 650 655

TGG GGA GAT AAC TTT ATT ATT TTG GAA ATT AGT CCT TCT GAA AAG TTA 2074 Trp Gly Asp Asn Phe lie lie Leu Glu lie Ser Pro Ser Glu Lys Leu 660 665 670

TTA AGT CCA GAA TTA ATT AAT ACA AAT AAT TGG ACG AGT ACG GGA TCA 2122 Leu Ser Pro Glu Leu lie Asn Thr Asn Asn Trp Thr Ser Thr Gly Ser 675 680 685

ACT AAT ATT AGC GGT AAT ACA CTC ACT CTT TAT CAG GGA GGA CGA GGG 2170 Thr Asn lie Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg Gly 690 695 700 705

ATT CTA AAA CAA AAC CTT CAA TTA GAT AGT TTT TCA ACT TAT AGA GTG 2218 lie Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg Val 710 715 720 TAT TTC TCT GTG TCC GGA GAT GCT AAT GTA AGG ATT AGA AAT TCT AGG 2266 Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg lie Arg Asn Ser Arg 725 730 735

GAA GTG TTA TTT GAA AAA AAG GAT ATA TGA GC GGCGCTAAAG ATGTTTCTGA 2318 Glu Val Leu Phe Glu Lys Lys Asp lie 740 745

AATGTTCACT ACAAAATTGA AAGATAACTT CTATATAGAG CTTTCT 2364

(2) INFORMATION FOR SEQ ID NO: 6:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 747 amino acids

(B) TYPE: amino acid (D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 6:

Met Asn Lys Asn Asn Ala Lys Leu Ser Thr Arg Ala Leu Pro Ser Phe 1 5 10 15 lie Asp Tyr Phe Asn Gly lie Tyr Gly Phe Ala Thr Gly lie Lys Asp 20 25 30 lie Met Asn Met lie Phe Lys Thr Asp Thr Gly Gly Asp Leu Ala Leu 35 40 45

Asp Glu lie Leu Glu Asn Gin Gin Leu Leu Asn Asp lie Ser Gly Lys 50 55 60

Leu Asp Gly Val Asn Gly Ser Leu Asn Asp Leu lie Ala Gin Gly Asn 65 70 75 80

Leu Asn Thr Glu Leu Ser Lys Glu lie Leu Lys lie Ala Asn Glu Gin 85 90 95

Asn Gin Val Leu Asn Asp Val Asn Asn Lys Leu Asp Ala lie Asn Thr 100 105 110

Met Leu Arg Val Tyr Leu Pro Lys lie Thr Ser Met Leu Ser Asp Val 115 120 125

Met Lys Gin Asn Tyr Ala Leu Ser Leu Gin lie Glu Tyr Leu Ser Lys 130 135 140

Gin Leu Gin Glu lie Ser Asp Lys Leu Asp lie lie Asn Val Asn Val 145 150 155 160

Leu lie Asn Ser Thr Leu Thr Glu lie Thr Pro Ala Tyr Gin Arg lie 165 170 175

Lys Tyr Val Asn Glu Lys Phe Glu Glu Leu Thr Phe Ala Thr Glu Thr 180 185 190

Ser Ser Lys Val Lys Lys Asp Gly Ser Pro Ala Asp lie Arg Asp Glu 195 200 205

Leu Ser Glu Leu Thr Glu Leu Ala Lys Ser Val Thr Gin Asn Asp Val 210 215 220

Asp Gly Phe Glu Phe Tyr Leu Asn Thr Phe His Asp Val Met Val Gly 225 230 235 240

Asn Asn Leu Phe Gly Arg Ser Ala Leu Lys Thr Ala Ser Glu Leu lie 245 250 255

Thr Lys Glu Asn Val Lys Thr Ser Gly Ser Glu Val Gly Asn Val Tyr 260 265 270

Asn Phe Leu lie Val Leu Thr Ala Leu Gin Ala Gin Ala Phe Leu Thr 275 280 285

Leu Thr Pro Cys Arg Lys Leu Leu Gly Leu Ala Asp lie Asp Tyr Thr 290 295 300

Ser lie Met Asn Glu His Leu Asn Lys Glu Lys Glu Glu Phe Arg Val 305 310 315 320

Asn lie Leu Pro Thr Leu Ser Asn Thr Phe Ser Asn Pro Asn Tyr Ala 325 330 335

Lys Val Lys Gly Ser Asp Glu Asp Ala Lys Met lie Val Glu Ala Lys 340 345 350

Pro Gly His Ala Leu lie Gly Phe Glu lie Ser Asn Asp Ser lie Thr 355 360 365

Val Leu Lys Val Tyr Glu Ala Lys Leu Lys Gin Asn Tyr Gin Val Asp 370 375 380

Lys Asp Ser Leu Ser Glu Val lie Tyr Gly Asp Met Asp Lys Leu Leu 385 390 395 400

Cys Pro Asp Gin Ser Gly Gin lie Tyr Tyr Thr Asn Asn lie Val Phe 405 410 415

Pro Asn Glu Tyr Val lie Thr Lys lie Asp Phe Thr Lys Lys Met Lys 420 425 430

Thr Leu Arg Tyr Glu Val Thr Ala Asn Phe Tyr Asp Ser Ser Thr Gly 435 440 445

Glu lie Asp Leu Asn Lys Lys Lys Val Glu Ser Ser Glu Ala Glu Tyr 450 455 460

Arg Thr Leu Ser Ala Asn Asp Asp Gly Val Tyr Met Pro Leu Gly Val 465 470 475 480 lie Ser Glu Thr Phe Leu Thr Pro lie Asn Gly Phe Gly Leu Gin Ala 485 490 495

Asp Glu Asn Ser Arg Leu lie Thr Leu Thr Cys Lys Ser Tyr Leu Arg 500 505 510

Glu Leu Leu Leu Ala Thr Asp Leu Ser Asn Lys Glu Thr Lys Leu lie 515 520 525

Val Pro Pro Ser Gly Phe lie Ser Asn lie Val Glu Asn Gly Ser lie 530 535 540

Glu Glu Asp Asn Leu Glu Pro Trp Lys Ala Asn Asn Lys Asn Ala Tyr 545 550 555 560

Val Asp His Thr Gly Gly Val Asn Gly Thr Lys Ala Leu Tyr Val His 565 570 575

Lys Asp Gly Gly lie Ser Gin Phe lie Gly Asp Lys Leu Lys Pro Lys 580 585 590

Thr Glu Tyr Val lie Gin Tyr Thr Val Lys Gly Lys Pro Ser lie His 595 600 605

Leu Lys Asp Glu Asn Thr Gly Tyr lie His Tyr Glu Asp Thr Asn Asn 610 615 620

Asn Leu Glu Asp Tyr Gin Thr lie Asn Lys Arg Phe Thr Thr Gly Thr 625 630 635 640

Asp Leu Lys Gly Val Tyr Leu lie Leu Lys Ser Gin Asn Gly Asp Glu 645 650 655

Ala Trp Gly Asp Asn Phe lie lie Leu Glu lie Ser Pro Ser Glu Lys 660 665 670

Leu Leu Ser Pro Glu Leu lie Asn Thr Asn Asn Trp Thr Ser Thr Gly 675 680 685

Ser Thr Asn lie Ser Gly Asn Thr Leu Thr Leu Tyr Gin Gly Gly Arg 690 695 700

Gly lie Leu Lys Gin Asn Leu Gin Leu Asp Ser Phe Ser Thr Tyr Arg 705 710 715 720

Val Tyr Phe Ser Val Ser Gly Asp Ala Asn Val Arg lie Arg Asn Ser 725 730 735

Arg Glu Val Leu Phe Glu Lys Lys Asp lie 740 745

(2) INFORMATION FOR SEQ ID NO: 7:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2403 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: other nucleic acid

(A) DESCRIPTION: /desc = "Synthetic DNA"

(iii) HYPOTHETICAL: NO

(ix) FEATURE:

(A) NAME/KEY: misc_feature

(B) LOCATION: 11..2389 (D) OTHER INFORMATION: /note= "maize optimized DNA sequence encoding VIP3A(a) "

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 7:

GGATCCACCA ATGAACATGA ACAAGAACAA CACCAAGCTG AGCACCCGCG CCCTGCCGAG 60

CTTCATCGAC TACTTCAACG GCATCTACGG CTTCGCCACC GGCATCAAGG ACATCATGAA 120

CATGATCTTC AAGACCGACA CCGGCGGCGA CCTGACCCTG GACGAGATCC TGAAGAACCA 180

GCAGCTGCTG AACGACATCA GCGGCAAGCT GGACGGCGTG AACGGCAGCC TGAACGACCT 240

GATCGCCCAG GGCAACCTGA ACACCGAGCT GAGCAAGGAG ATCCTTAAGA TCGCCAACGA 300

GCAGAACCAG GTGCTGAACG ACGTGAACAA CAAGCTGGAC GCCATCAACA CCATGCTGCG 360

CGTGTACCTG CCGAAGATCA CCAGCATGCT GAGCGACGTG ATGAAGCAGA ACTACGCCCT 420

GAGCCTGCAG ATCGAGTACC TGAGCAAGCA GCTGCAGGAG ATCAGCGACA AGCTGGACAT 480

CATCAACGTG AACGTCCTGA TCAACAGCAC CCTGACCGAG ATCACCCCGG CCTACCAGCG 540

CATCAAGTAC GTGAACGAGA AGTTCGAAGA GCTGACCTTC GCCACCGAGA CCAGCAGCAA 600

GGTGAAGAAG GACGGCAGCC CGGCCGACAT CCTGGACGAG CTGACCGAGC TGACCGAGCT 660

GGCCAAGAGC GTGACCAAGA ACGACGTGGA CGGCTTCGAG TTCTACCTGA ACACCTTCCA 720

CGACGTGATG GTGGGCAACA ACCTGTTCGG CCGCAGCGCC CTGAAGACCG CCAGCGAGCT 780

GATCACCAAG GAGAACGTGA AGACCAGCGG CAGCGAGGTG GGCAACGTGT ACAACTTCCT 840

GATCGTGCTG ACCGCCCTGC AGGCCCAGGC CTTCCTGACC CTGACCACCT GTCGCAAGCT 900

GCTGGGCCTG GCCGACATCG ACTACACCAG CATCATGAAC GAGCACTTGA ACAAGGAGAA 960

GGAGGAGTTC CGCGTGAACA TCCTGCCGAC CCTGAGCAAC ACCTTCAGCA ACCCGAACTA 1020

CGCCAAGGTG AAGGGCAGCG ACGAGGACGC CAAGATGATC GTGGAGGCTA AGCCGGGCCA 1080

CGCGTTGATC GGCTTCGAGA TCAGCAACGA CAGCATCACC GTGCTGAAGG TGTACGAGGC 1140

CAAGCTGAAG CAGAACTACC AGGTGGACAA GGACAGCTTG AGCGAGGTGA TCTACGGCGA 1200

CATGGACAAG CTGCTGTGTC CGGACCAGAG CGAGCAAATC TACTACACCA ACAACATCGT 1260

GTTCCCGAAC GAGTACGTGA TCACCAAGAT CGACTTCACC AAGAAGATGA AGACCCTGCG 1320

CTACGAGGTG ACCGCCAACT TCTACGACAG CAGCACCGGC GAGATCGACC TGAACAAGAA 1380

GAAGGTGGAG AGCAGCGAGG CCGAGTACCG CACCCTGAGC GCGAACGACG ACGGCGTCTA 1440

CATGCCACTG GGCGTGATCA GCGAGACCTT CCTGACCCCG ATCAACGGCT TTGGCCTGCA 1500

GGCCGACGAG AACAGCCGCC TGATCACCCT GACCTGTAAG AGCTACCTGC GCGAGCTGCT 1560

GCTAGCCACC GACCTGAGCA ACAAGGAGAC CAAGCTGATC GTGCCACCGA GCGGCTTCAT 1620

CAGCAACATC GTGGAGAACG GCAGCATCGA GGAGGACAAC CTGGAGCCGT GGAAGGCCAA 1680

CAACAAGAAC GCCTACGTGG ACCACACCGG CGGCGTGAAC GGCACCAAGG CCCTGTACGT 1740

GCACAAGGAC GGCGGCATCA GCCAGTTCAT CGGCGACAAG CTGAAGCCGA AGACCGAGTA 1800 CGTGATCCAG TACACCGTGA AGGGCAAGCC ATCGATTCAC CTGAAGGACG AGAACACCGG 1860

CTACATCCAC TACGAGGACA CCAACAACAA CCTGGAGGAC TACCAGACCA TCAACAAGCG 1920

CTTCACCACC GGCACCGACC TGAAGGGCGT GTACCTGATC CTGAAGAGCC AGAACGGCGA 1980

CGAGGCCTGG GGCGACAACT TCATCATCCT GGAGATCAGC CCGAGCGAGA AGCTGCTGAG 2040

CCCGGAGCTG ATCAACACCA ACAACTGGAC CAGCACCGGC AGCACCAACA TCAGCGGCAA 2100

CACCCTGACC CTGTACCAGG GCGGCCGCGG CATCCTGAAG CAGAACCTGC AGCTGGACAG 2160

CTTCAGCACC TACCGCGTGT ACTTCAGCGT GAGCGGCGAC GCCAACGTGC GCATCCGCAA 2220

CAGCCGCGAG GTGCTGTTCG AGAAGAGGTA CATGAGCGGC GCCAAGGACG TGAGCGAGAT 2280

GTTCACCACC AAGTTCGAGA AGGACAACTT CTACATCGAG CTGAGCCAGG GCAACAACCT 2340

GTACGGCGGC CCGATCGTGC ACTTCTACGA CGTGAGCATC AAGTTAACGT AGAGCTCAGA 2400

TCT 2403

(2) INFORMATION FOR SEQ ID NO: 8:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 1638 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS : single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: cDNA (iii) HYPOTHETICAL: NO

(ix) FEATURE:

(A) NAME/KEY: CDS

(B) LOCATION: 44..1191

(D) OTHER INFORMATION: /product= "Translation of cDNA encoding VIP3A(a) receptor"

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 8:

T AGT GGA TCC CCC GGG CTG CAG GAA TTC GCG GCC GCG TCG ACC ATG 46

Met 1 5 10 15

TAC TCT AGA ATA TTT TTC CTC CTT GTG ATA GTG TGT GCT GTT AAG GCT 94 Tyr Ser Arg He Phe Phe Leu Leu Val He Val Cys Ala Val Lys Ala 20 25 30

TCT CTG TTT ACT GTA AAT GTG TAT GAT GAT AAC CCC GAA ACT GAA ATT 142 Ser Leu Phe Thr Val Asn Val Tyr Asp Asp Asn Pro Glu Thr Glu He 35 40 45

GCG AGT AGT CTA AAA GGC TGT AAC CCC CAA GAG TGT GAC CAG CGG TGT 190 Ala Ser Ser Leu Lys Gly Cys Asn Pro Gin Glu Cys Asp Gin Arg Cys 50 55 60 CGT AGA CTG AAG TTT CCC GGT GGC GCC TGT GTC AAT GGT CGC TGC AAG 238 Arg Arg Leu Lys Phe Pro Gly Gly Ala Cys Val Asn Gly Arg Cys Lys 65 70 75

TGT GAC AAC TTC CTC AGT GTA AAA GAT GAC GTG TCT GTT GAA GAG CCT 286 Cys Asp Asn Phe Leu Ser Val Lys Asp Asp Val Ser Val Glu Glu Pro 80 85 90 95

GCG ATT CTC AAA GAT TTG GTG TCA TTA GAA GCT GAA CAG GCA GCG AAA 334 Ala He Leu Lys Asp Leu Val Ser Leu Glu Ala Glu Gin Ala Ala Lys 100 105 110

AGT AGA TGC AGA AAC AGA GTG TGT GAC GCG GTG TGC CGT GCC CTA CAC 382 Ser Arg Cys Arg Asn Arg Val Cys Asp Ala Val Cys Arg Ala Leu His 115 120 125

AAC ACC AGT GGT GCC TGT GTT GAT GGA CAA TGC AAG TGT ACT AAT AAG 430 Asn Thr Ser Gly Ala Cys Val Asp Gly Gin Cys Lys Cys Thr Asn Lys 130 135 140

ATC AGT GCA GGA GAT ATT GTG TCT GAT CCT GCT GAA TCG CTA CGC ACT 478 He Ser Ala Gly Asp He Val Ser Asp Pro Ala Glu Ser Leu Arg Thr 145 150 155

TGT AAC CCT ATA AGG TGT GAC GAA CAA TGT AGA AGA AAT GGC CAT GAA 526 Cys Asn Pro He Arg Cys Asp Glu Gin Cys Arg Arg Asn Gly His Glu 160 165 170 175

TTT GGT GTT TGC TTC AAA GGA CAA TGC AAG TGT GAT TAC TTC CTC AAG 574 Phe Gly Val Cys Phe Lys Gly Gin Cys Lys Cys Asp Tyr Phe Leu Lys 180 185 190

GAA GAA GTC GAT GAA CCT GAA GTT ACA AGC CTT CCA AAA AAC TGC AAC 622 Glu Glu Val Asp Glu Pro Glu Val Thr Ser Leu Pro Lys Asn Cys Asn 195 200 205

CCC CAA GAG TGT GAC CAG CGT TGT CGT AGA CTG AAG TTC CCC GGT GGC 670 Pro Gin Glu Cys Asp Gin Arg Cys Arg Arg Leu Lys Phe Pro Gly Gly 210 215 220

GCC TGT GTC AAC GGG CGC TGC AAG TGT GAC AAC TTC TTC AGT GCA GGA 718 Ala Cys Val Asn Gly Arg Cys Lys Cys Asp Asn Phe Phe Ser Ala Gly 225 230 235

GAT ATT GTG TCT GAT CCT GCC GAA TCG CTA CGC TCT TGT AAC CCT ATA 766 Asp He Val Ser Asp Pro Ala Glu Ser Leu Arg Ser Cys Asn Pro He 240 245 250 255

AGG TGT GAC GAA CAA TGT AGA AGA AAT GGC CAT GAA TTT GGT GTT TGC 814 Arg Cys Asp Glu Gin Cys Arg Arg Asn Gly His Glu Phe Gly Val Cys 260 265 270

TTC AAA GGA CAA TGC AAG TGT GAT TAC TTC CTC AAC TCA GAA GTA GAC 862 Phe Lys Gly Gin Cys Lys Cys Asp Tyr Phe Leu Asn Ser Glu Val Asp 275 280 285

GCT GTT AAT GAG TTT CCT CAA GCG GGC TCA AAA CGC TAC TGC AAC TTA 910 Ala Val Asn Glu Phe Pro Gin Ala Gly Ser Lys Arg Tyr Cys Asn Leu 290 295 300 ACG CAA TGC AAC CAG ACG TGC GCC AAT CGT TTC TAT GAT AGT GCT AGA 958 Thr Gin Cys Asn Gin Thr Cys Ala Asn Arg Phe Tyr Asp Ser Ala Arg 305 310 315

GTG ATC CAC GGC TGG TGC AAA TGC TAC AGT AAG ATG GAA AGA CAG GAT 1006 Val He His Gly Trp Cys Lys Cys Tyr Ser Lys Met Glu Arg Gin Asp 320 325 330 335

GCA TCT CCA TTA AAC GAT GTG ACT GAG GAT GAA AAT GAA GTT TCT AAC 1054 Ala Ser Pro Leu Asn Asp Val Thr Glu Asp Glu Asn Glu Val Ser Asn 340 345 350

GAT ATC CTG AGG ACT GTT GCA GAG GAG CTG TCT GAT GTG TCA CCT AGG 1102 Asp He Leu Arg Thr Val Ala Glu Glu Leu Ser Asp Val Ser Pro Arg 355 360 365

GCC TGC AAA TCA GCG AGC TGC AAT CAA GCA TGT CGC GCC TTC TAC TTT 1150 Ala Cys Lys Ser Ala Ser Cys Asn Gin Ala Cys Arg Ala Phe Tyr Phe 370 375 380

AAA GGA GGG TGG TGT CGC TTT GGA CGA TGC CAA TGC TTC TA 1191

Lys Gly Gly Trp Cys Arg Phe Gly Arg Cys Gin Cys Phe 385 390 395

AAATTAGTAT GATATATGAA TTTTGTATTA TTCGGTTAAT TGTGTTATGT TTAAAAAACA 1251

TAATGTCTTC ATTTTAGAAA AAAGTACCTT CACTAAAGCG CAACAATTAA CTAGTAGTTA 1311

ATTATTAACT AGTAGTTAAA TTATTGATGA TTATGATTAT CTTAGTAGTA GTTAATTATA 1371

ATCATCAACT ATTAACTAGT AGTTAATTAT TAACTAGTAG TTAAATTATT GATGATTATG 1431

ATTATCTTAG TAGTAGTTAA TTATTGTTTC TTATAATAAT CTAGTATGTT GGTAGGTACT 1491

TAATAATAAC GCTTCTGACA AAAAATTTAA AATTAAATAA TTCTATCAAA CATAAATAAT 1551

AACTGAAATA AAAATTTATA AGAGAAAAAA AAAAAGTCGA CGCGGCCGCG AATTCGATAT 1611

CAAGCTTATC GATACCGTCG ACCTCGA 1638

(2) INFORMATION FOR SEQ ID NO: 9:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 396 amino acids

(B) TYPE: amino acid (D) TOPOLOGY: linear

(ii) MOLECULE TYPE: protein

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 9:

Ser Gly Ser Pro Gly Leu Gin Glu Phe Ala Ala Ala Ser Thr Met Tyr 1 5 10 15

Ser Arg He Phe Phe Leu Leu Val He Val Cys Ala Val Lys Ala Ser 20 25 30

Leu Phe Thr Val Asn Val Tyr Asp Asp Asn Pro Glu Thr Glu He Ala 35 40 45 Ser Ser Leu Lys Gly Cys Asn Pro Gin Glu Cys Asp Gin Arg Cys Arg 50 55 60

Arg Leu Lys Phe Pro Gly Gly Ala Cys Val Asn Gly Arg Cys Lys Cys 65 70 75 80

Asp Asn Phe Leu Ser Val Lys Asp Asp Val Ser Val Glu Glu Pro Ala 85 90 95

He Leu Lys Asp Leu Val Ser Leu Glu Ala Glu Gin Ala Ala Lys Ser 100 105 110

Arg Cys Arg Asn Arg Val Cys Asp Ala Val Cys Arg Ala Leu His Asn 115 120 125

Thr Ser Gly Ala Cys Val Asp Gly Gin Cys Lys Cys Thr Asn Lys He 130 135 140

Ser Ala Gly Asp He Val Ser Asp Pro Ala Glu Ser Leu Arg Thr Cys 145 150 155 160

Asn Pro He Arg Cys Asp Glu Gin Cys Arg Arg Asn Gly His Glu Phe 165 170 175

Gly Val Cys Phe Lys Gly Gin Cys Lys Cys Asp Tyr Phe Leu Lys Glu 180 185 190

Glu Val Asp Glu Pro Glu Val Thr Ser Leu Pro Lys Asn Cys Asn Pro 195 200 205

Gin Glu Cys Asp Gin Arg Cys Arg Arg Leu Lys Phe Pro Gly Gly Ala 210 215 220

Cys Val Asn Gly Arg Cys Lys Cys Asp Asn Phe Phe Ser Ala Gly Asp 225 230 235 240

He Val Ser Asp Pro Ala Glu Ser Leu Arg Ser Cys Asn Pro He Arg 245 250 255

Cys Asp Glu Gin Cys Arg Arg Asn Gly His Glu Phe Gly Val Cys Phe 260 265 270

Lys Gly Gin Cys Lys Cys Asp Tyr Phe Leu Asn Ser Glu Val Asp Ala 275 280 285

Val Asn Glu Phe Pro Gin Ala Gly Ser Lys Arg Tyr Cys Asn Leu Thr 290 295 300

Gin Cys Asn Gin Thr Cys Ala Asn Arg Phe Tyr Asp Ser Ala Arg Val 305 310 315 320

He His Gly Trp Cys Lys Cys Tyr Ser Lys Met Glu Arg Gin Asp Ala 325 330 335

Ser Pro Leu Asn Asp Val Thr Glu Asp Glu Asn Glu Val Ser Asn Asp 340 345 350

He Leu Arg Thr Val Ala Glu Glu Leu Ser Asp Val Ser Pro Arg Ala 355 360 365 Cys Lys Ser Ala Ser Cys Asn Gin Ala Cys Arg Ala Phe Tyr Phe Lys 370 375 380

Gly Gly Trp Cys Arg Phe Gly Arg Cys Gin Cys Phe 385 390 395

(2) INFORMATION FOR SEQ ID NO: 10:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 14 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS : single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO

(v) FRAGMENT TYPE: N-terminal

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Bacillus thuringiensis

(B) STRAIN: AB88

(ix) FEATURE:

(A) NAME/KEY: Peptide

(B) LOCATION: 1..14

(D) OTHER INFORMATION: /note= "N-terminal amino acid sequence of protein knovm as anion exchange fraction 23 (smaller) "

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:10:

Xaa Glu Pro Phe Val Ser Ala Xaa Xaa Xaa Gin Xaa Xaa Xaa

1 5 10

(2) INFORMATION FOR SEQ ID NO: 11:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 13 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Bacillus thuringiensis

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 11:

Xaa Glu Tyr Glu Asn Val Glu Pro Phe Val Ser Ala Xaa 1 5 10

(2) INFORMATION FOR SEQ ID NO: 12:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 14 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single (D) TOPOLOGY: linear

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Bacillus thurigiensis

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:12:

Met Asn Lys Asn Asn Thr Lys Leu Pro Thr Arg Ala Leu Pro 1 5 10

(2) INFORMATION FOR SEQ ID NO: 13:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 15 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO

(v) FRAGMENT TYPE: N-terminal

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Bacillus thuringiensis

(B) STRAIN: AB88

(ix) FEATURE:

(A) NAME/KEY: Peptide

(B) LOCATION: 1..15

(D) OTHER INFORMATION: /note= "N-terminal amino acid sequence of 35 kDa VIP active against Agrotis ipsilon"

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:13:

Ala Leu Ser Glu Asn Thr Gly Lys Asp Gly Gly Tyr He Val Pro 1 5 10 15

(2) INFORMATION FOR SEQ ID NO: 14:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 9 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Bacillus thuringiensis

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 14:

Met Asp Asn Asn Pro Asn He Asn Glu 1 5

(2) INFORMATION FOR SEQ ID NO: 15:

(i) SEQUENCE CHARACTERISTICS: (A) LENGTH: 9 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: peptide (iii) HYPOTHETICAL: NO

(v) FRAGMENT TYPE: N-terminal

(ix) FEATURE:

(A) NAME/KEY: Peptide

(B) LOCATION: 1..9

(D) OTHER INFORMATION: /note= "N-terminal sequence of 80 kDa delta-endotoxin"

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 15:

Met Asp Asn Asn Pro Asn He Asn Glu 1 5

(2) INFORMATION FOR SEQ ID NO: 16:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 11 amino acids

(B) TYPE: amino acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: peptide

(iii) HYPOTHETICAL: NO

(v) FRAGMENT TYPE: N-terminal

(vi) ORIGINAL SOURCE:

(A) ORGANISM: Bacillus thuringiensis

(ix) FEATURE:

(A) NAME/KEY: Peptide

(B) LOCATION: 1..11

(D) OTHER INFORMATION: /note= "N-terminal sequence from 60 kDa delta-endotoxin"

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 16:

Met Asn Val Leu Asn Ser Gly Arg Thr Thr He 1 5 10

(2) INFORMATION FOR SEQ ID NO: 17:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 17 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: other nucleic acid

(A) DESCRIPTION: /desc = "primer sequence" (iii) HYPOTHETICAL: NO

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 17: CGATTAATGT TGGCCTC 17

(2) INFORMATION FOR SEQ ID NO: 18:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 21 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: other nucleic acid

(A) DESCRIPTION: /desc = "primer sequence"

(iii) HYPOTHETICAL: NO

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 18: CATTAGCATC TCCGGACACA G 21

(2) INFORMATION FOR SEQ ID NO: 19:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2370 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: other nucleic acid

(A) DESCRIPTION: /desc = "synthetic DNA encoding VIP3A(b) "

(iii) HYPOTHETICAL: NO

(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 19:

ATGAACAAGA ACAACACCAA GCTGAGCACC CGCGCCCTGC CGAGCTTCAT CGACTACTTC 60

AACGGCATCT ACGGCTTCGC CACCGGCATC AAGGACATCA TGAACATGAT CTTCAAGACC 120

GACACCGGCG GCGACCTGAC CCTGGACGAG ATCCTGAAGA ACCAGCAGCT GCTGAACGAC 180

ATCAGCGGCA AGCTGGACGG CGTGAACGGC AGCCTGAACG ACCTGATCGC CCAGGGCAAC 240

CTGAACACCG AGCTGAGCAA GGAGATCCTT AAGATCGCCA ACGAGCAGAA CCAGGTGCTG 300

AACGACGTGA ACAACAAGCT GGACGCCATC AACACCATGC TGCGCGTGTA CCTGCCGAAG 360 ATCACCAGCA TGCTGAGCGA CGTGATGAAG CAGAACTACG CCCTGAGCCT GCAGATCGAG 420 TACCTGAGCA AGCAGCTGCA GGAGATCAGC GACAAGCTGG ACATCATCAA CGTGAACGTC 480 CTGATCAACA GCACCCTGAC CGAGATCACC CCGGCCTACC AGCGCATCAA GTACGTGAAC 540 GAGAAGTTCG AAGAGCTGAC CTTCGCCACC GAGACCAGCA GCAAGGTGAA GAAGGACGGC 600 AGCCCGGCCG ACATCCTGGA CGAGCTGACC GAGCTGACCG AGCTGGCGAA GAGCGTGACC 660 AAGAACGACG TGGACGGCTT CGAGTTCTAC CTGAACACCT TCCACGACGT GATGGTGGGC 720 AACAACCTGT TCGGCCGCAG CGCCCTGAAG ACCGCCAGCG AGCTGATCAC CAAGGAGAAC 780 GTGAAGACCA GCGGCAGCGA GGTGGGCAAC GTGTACAACT TCCTGATCGT GCTGACCGCC 840 CTGCAGGCCA AGGCCTTCCT GACCCTGACC CCCTGTCGCA AGCTGCTGGG CCTGGCCGAC 900 ATCGACTACA CCAGCATCAT GAACGAGCAC TTGAACAAGG AGAAGGAGGA GTTCCGCGTG 960 AACATCCTGC CGACCCTGAG CAACACCTTC AGCAACCCGA ACTACGCCAA GGTGAAGGGC 1020 AGCGACGAGG ACGCCAAGAT GATCGTGGAG GCTAAGCCGG GCCACGCGTT GATCGGCTTC 1080 GAGATCAGCA ACGACAGCAT CACCGTGCTG AAGGTGTACG AGGCCAAGCT GAAGCAGAAC 1140 TACCAGGTGG ACAAGGACAG CTTGAGCGAG GTGATCTACG GCGACATGGA CAAGCTGCTG 1200 TGTCCGGACC AGAGCGGGCA AATCTACTAC ACCAACAACA TCGTGTTCCC GAACGAGTAC 1260 GTGATCACCA AGATCGACTT CACCAAGAAG ATGAAGACCC TGCGCTACGA GGTGACCGCC 1320 AACTTCTACG ACAGCAGCAC CGGCGAGATC GACCTGAACA AGAAGAAGGT GGAGAGCAGC 1380 GAGGCCGAGT ACCGCACCCT GAGCGCGAAC GACGACGGCG TCTACATGCC ACTGGGCGTG 1440 ATCAGCGAGA CCTTCCTGAC CCCGATCAAC GGCTTTGGCC TGCAGGCCGA CGAGAACAGC 1500 CGCCTGATCA CCCTGACCTG TAAGAGCTAC CTGCGCGAGC TGCTGCTAGC CACCGACCTG 1560 AGCAACAAGG AGACCAAGCT GATCGTGCCA CCGAGCGGCT TCATCAGCAA CATCGTGGAG 1620 AACGGCAGCA TCGAGGAGGA CAACCTGGAG CCGTGGAAGG CCAACAACAA GAACGCCTAC 1680 GTGGACCACA CCGGCGGCGT GAACGGCACC AAGGCCCTGT ACGTGCACAA GGACGGCGGC 1740 ATCAGCCAGT TCATCGGCGA CAAGCTGAAG CCGAAGACCG AGTACGTGAT CCAGTACACC 1800 GTGAAGGGCA AGCCATCGAT TCACCTGAAG GACGAGAACA CCGGCTACAT CCACTACGAG 1860 GACACCAACA ACAACCTGGA GGACTACCAG ACCATCAACA AGCGCTTCAC CACCGGCACC 1920 GACCTGAAGG GCGTGTACCT GATCCTGAAG AGCCAGAACG GCGACGAGGC CTGGGGCGAC 1980 AACTTCATCA TCCTGGAGAT CAGCCCGAGC GAGAAGCTGC TGAGCCCGGA GCTGATCAAC 2040 ACCAACAACT GGACCAGCAC CGGCAGCACC AACATCAGCG GCAACACCCT GACCCTGTAC 2100 CAGGGCGGCC GCGGCATCCT GAAGCAGAAC CTGCAGCTGG ACAGCTTCAG CACCTACCGC 2160 GTGTACTTCA GCGTGAGCGG CGACGCCAAC GTGCGCATCC GCAACTCCCG CGAGGTGCTG 2220

TTCAAGAAGA GGTACATGAG CGGCGCCAAG GACGTGAGCG AGATGTTCAC CACCAAGTTC 2280

GAGAAGGACA ACTTCTACAT CGAGCTGAGC CAGGGCAACA ACCTGTACGG CGGCCCGATC 2340

GTGCACTTCT ACGACGTGAG CATCAAGTAG 2370 (2) INFORMATION FOR SEQ ID NO: 20:

(i) SEQUENCE CHARACTERISTICS:

(A) LENGTH: 2241 base pairs

(B) TYPE: nucleic acid

(C) STRANDEDNESS: single

(D) TOPOLOGY: linear

(ii) MOLECULE TYPE: other nucleic acid

(A) DESCRIPTION: /desc = "synthetic DNA encoding VIP3A(c) "

(iii) HYPOTHETICAL: NO

(xi) SEQUENCE DESCRIPTION: SEQ ID NO:20:

ATGAACAAGA ACAACGCCAA GCTGAGCACC CGCGCCCTGC CGAGCTTCAT CGACTACTTC 60

AACGGCATCT ACGGCTTCGC CACCGGCATC AAGGACATCA TGAACATGAT CTTCAAGACC 120

GACACCGGCG GCGACCTGGC CCTGGACGAG ATCCTGGAGA ACCAGCAGCT GCTGAACGAC 180

ATCAGCGGCA AGCTGGACGG CGTGAACGGC AGCCTGAACG ACCTGATCGC CCAGGGCAAC 240

CTGAACACCG AGCTGAGCAA GGAGATCCTT AAGATCGCCA ACGAGCAGAA CCAGGTGCTG 300

AACGACGTGA ACAACAAGCT GGACGCCATC AACACCATGC TGCGCGTGTA CCTGCCGAAG 360

ATCACCAGCA TGCTGAGCGA CGTGATGAAG CAGAACTACG CCCTGAGCCT GCAGATCGAG 420

TACCTGAGCA AGCAGCTGCA GGAGATCAGC GACAAGCTGG ACATCATCAA CGTGAACGTC 480

CTGATCAACA GCACCCTGAC CGAGATCACC CCGGCCTACC AGCGCATCAA GTACGTGAAC 540

GAGAAGTTCG AAGAGCTGAC CTTCGCCACC GAGACCAGCA GCAAGGTGAA GAAGGACGGC 600

AGCCCGGCCG ACATCCGGGA CGAGCTGAGC GAGCTGACCG AGCTGGCGAA GAGCGTGACC 660

CAGAACGACG TGGACGGCTT CGAGTTCTAC CTGAACACCT TCCACGACGT GATGGTGGGC 720

AACAACCTGT TCGGCCGCAG CGCCCTGAAG ACCGCCAGCG AGCTGATCAC CAAGGAGAAC 780

GTGAAGACCA GCGGCAGCGA GGTGGGCAAC GTGTACAACT TCCTGATCGT GCTGACCGCC 840

CTGCAGGCCC AGGCCTTCCT GACCCTGACC CCCTGTCGCA AGCTGCTGGG CCTGGCCGAC 900

ATCGACTACA CCAGCATCAT GAACGAGCAC TTGAACAAGG AGAAGGAGGA GTTCCGCGTG 960 AACATCCTGC CGACCCTGAG CAACACCTTC AGCAACCCGA ACTACGCCAA GGTGAAGGGC 1020

AGCGACGAGG ACGCCAAGAT GATCGTGGAG GCTAAGCCGG GCCACGCGTT GATCGGCTTC 1080

GAGATCAGCA ACGACAGCAT CACCGTGCTG AAGGTGTACG AGGCCAAGCT GAAGCAGAAC 1140

TACCAGGTGG ACAAGGACAG CTTGAGCGAG GTGATCTACG GCGACATGGA CAAGCTGCTG 1200

TGTCCGGACC AGAGCGGGCA AATCTACTAC ACCAACAACA TCGTGTTCCC GAACGAGTAC 1260

GTGATCACCA AGATCGACTT CACCAAGAAG ATGAAGACCC TGCGCTACGA GGTGACCGCC 1320

AACTTCTACG ACAGCAGCAC CGGCGAGATC GACCTGAACA AGAAGAAGGT GGAGAGCAGC 1380

GAGGCCGAGT ACCGCACCCT GAGCGCGAAC GACGACGGCG TCTACATGCC ACTGGGCGTG 1440

ATCAGCGAGA CCTTCCTGAC CCCGATCAAC GGCTTTGGCC TGCAGGCCGA CGAGAACAGC 1500

CGCCTGATCA CCCTGACCTG TAAGAGCTAC CTGCGCGAGC TGCTGCTAGC CACCGACCTG 1560

AGCAACAAGG AGACCAAGCT GATCGTGCCA CCGAGCGGCT TCATCAGCAA CATCGTGGAG 1620

AACGGCAGCA TCGAGGAGGA CAACCTGGAG CCGTGGAAGG CCAACAACAA GAACGCCTAC 1680

GTGGACCACA CCGGCGGCGT GAACGGCACC AAGGCCCTGT ACGTGCACAA GGACGGCGGC 1740

ATCAGCCAGT TCATCGGCGA CAAGCTGAAG CCGAAGACCG AGTACGTGAT CCAGTACACC 1800

GTGAAGGGCA AGCCATCGAT TCACCTGAAG GACGAGAACA CCGGCTACAT CCACTACGAG 1860

GACACCAACA ACAACCTGGA GGACTACCAG ACCATCAACA AGCGCTTCAC CACCGGCACC 1920

GACCTGAAGG GCGTGTACCT GATCCTGAAG AGCCAGAACG GCGACGAGGC CTGGGGCGAC 1980

AACTTCATCA TCCTGGAGAT CAGCCCGAGC GAGAAGCTGC TGAGCCCGGA GCTGATCAAC 2040

ACCAACAACT GGACCAGCAC CGGCAGCACC AACATCAGCG GCAACACCCT GACCCTGTAC 2100

CAGGGCGGCC GCGGCATCCT GAAGCAGAAC CTGCAGCTGG ACAGCTTCAG CACCTACCGC 2160

GTGTACTTCA GCGTGAGCGG CGACGCCAAC GTGCGCATCC GCAACTCCCG CGAGGTGCTG 2220

TTCGAGAAGA AGGACAAGTA G 2241